, Un domaine transmembranaire (TM, acides aminés 1039-1059) relie la région extracellulaire à la région juxtamembranaire (JM, 1060-1115) du domaine intracellulaire (1060-1620). Le domaine tyrosine kinase (TKD) s'étend des acides aminés 1116 à 1383 et est suivi d, La région N-terminale de ALK humain comprend deux domaines MAM (Meprin
, , 2011.
, The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells, Blood, vol.66, pp.848-58, 1985.
, Classification OMS 2008 des lymphomes, Ann. Pathol, vol.28, pp.20-24, 2008.
DOI : 10.1016/j.annpat.2008.09.002
, The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications, Blood, vol.117, pp.5019-5051, 2011.
, Gene-expression profiling of systemic anaplastic large-cell lymphoma reveals differences based on ALK status and two distinct morphologic ALK+ subtypes, Blood, vol.109, pp.2156-64, 2007.
, Report of the Committee on Hodgkin's Disease Staging Classification, Cancer Res, vol.31, pp.1860-1861, 1971.
, Classification, staging and end results of treatment of childhood non-Hodgkin's lymphomas: dissimilarities from lymphomas in adults, Semin. Oncol, vol.7, pp.332-341, 1980.
, Clinical Presentation and Staging, 2003.
, ALK-anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project, Blood, vol.111, pp.5496-504, 2008.
, Childhood non-Hodgkin lymphomas in the United Kingdom: findings from the UK Children's Cancer Study Group, J. Clin. Pathol, vol.50, pp.128-162, 1997.
, Adolescent non-Hodgkin lymphoma and Hodgkin lymphoma: state of the science, Br. J. Haematol, vol.144, pp.24-40, 2009.
, Prognostic factors in childhood anaplastic large cell lymphoma: results of a large European intergroup study, Blood, vol.111, pp.1560-1566, 2008.
, ALK+ lymphoma: clinico-pathological findings and outcome, Blood, vol.93, pp.2697-706, 1999.
, Cutaneous presentation of ALK-positive anaplastic large cell lymphoma following insect bites: evidence for an association in five cases, Haematologica, vol.95, pp.449-55, 2010.
, Occupation and lymphoid neoplasms, Br. J. Cancer, vol.60, pp.385-393, 1989.
, Bone marrow involvement in anaplastic large cell lymphoma. Immunohistochemical detection of minimal disease and its prognostic significance, Am. J. Clin. Pathol, vol.103, pp.82-91, 1995.
, ALK-positive anaplastic large cell lymphoma: an evolving story, Front. Biosci. (Schol. Ed), vol.7, pp.248-59, 2015.
, ALK-positive anaplastic large cell lymphoma: an evolving story, Front. Biosci. (Schol. Ed), vol.7, pp.248-59, 2015.
, CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features, Blood, vol.96, pp.3681-95, 2000.
, ALK-positive lymphoma: a single disease with a broad spectrum of morphology, Blood, vol.91, pp.2076-84, 1998.
,
, WHO Classification of Tumors of Haematopoietic and Lympoid Tissues, 2008.
, Prognostic impact of morphologic and phenotypic features of childhood ALKpositive anaplastic large-cell lymphoma: results of the ALCL99 study, J. Clin. Oncol, vol.29, pp.4669-76, 2011.
, Lymphohistiocytic T-cell lymphoma (anaplastic large cell lymphoma CD30+
, + with a high content of reactive histiocytes), Histopathology, vol.16, pp.383-91, 1990.
, ALK-positive anaplastic large cell lymphoma mimicking nodular sclerosis Hodgkin's lymphoma: report of 10 cases, Am. J. Surg. Pathol, vol.30, pp.223-232, 2006.
, A small-cell-predominant variant of primary Ki-1 (CD30)+ T-cell lymphoma, Am. J. Surg. Pathol, vol.17, pp.859-68, 1993.
, miR-135b mediates NPM-ALK-driven oncogenicity and renders IL-17-producing immunophenotype to anaplastic large cell lymphoma, Blood, vol.118, pp.6881-92, 2011.
, Anaplastic large cell lymphoma in paediatric and young adult patients, Br. J. Haematol, vol.173, pp.560-72, 2016.
, Anaplastic large-cell lymphomas of T-cell and null-cell phenotype express cytotoxic molecules, Blood, vol.88, pp.4005-4016, 1996.
, Intratumoral heterogeneity in anaplastic large cell lymphoma of noncommon subtype, J. Hematop, vol.5, pp.109-116, 2012.
, MUC1 (EMA) is preferentially expressed by ALK positive anaplastic large cell lymphoma, in the normally glycosylated or only partly hypoglycosylated form, J. Clin. Pathol, vol.54, pp.933-942, 2001.
, Detection of differentially expressed genes in lymphomas using cDNA arrays: identification of clusterin as a new diagnostic marker for anaplastic large-cell lymphomas, Blood, vol.96, pp.398-404, 2000.
, NPM-ALK-dependent expression of the transcription factor CCAAT/enhancer binding protein beta in ALK-positive anaplastic large cell lymphoma, Blood, vol.108, pp.2029-2065, 2006.
, The potent oncogene NPM-ALK mediates malignant transformation of normal human CD4(+) T lymphocytes, Am. J. Pathol, vol.183, pp.1971-80, 2013.
, T-cell receptor diversity prevents T-cell lymphoma development, Leukemia, vol.26, pp.2499-507, 2012.
, Anaplastic large cell lymphoma-propagating cells are detectable by side population analysis and possess an expression profile reflective of a primitive origin, Oncogene, vol.34, pp.1843-52, 2015.
, Circulating t(2;5)-positive cells can be detected in cord blood of healthy newborns, Leukemia, vol.26, pp.188-190, 2012.
, Detection of the t(2;5)-associated NPM/ALK fusion cDNA in peripheral blood cells of healthy individuals, Br. J. Haematol, vol.103, pp.1138-1182, 1998.
, Anaplastic large cell lymphoma arises in thymocytes and requires transient TCR expression for thymic egress, Nat. Commun, vol.7, p.10087, 2016.
, Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in nonHodgkin's lymphoma, Science, vol.263, pp.1281-1285, 1994.
, Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system, Oncogene, vol.14, pp.439-488, 1997.
, ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK), Oncogene, vol.14, pp.2175-88, 1997.
, An SCF-like ubiquitin ligase complex that controls presynaptic differentiation, Nature, vol.430, pp.345-50, 2004.
DOI : 10.1038/nature02647
, Involvement of genes required for synaptic function in aging control in C. elegans, Neurosci. Bull, vol.23, pp.21-30, 2007.
, Jelly belly: a Drosophila LDL receptor repeat-containing signal required for mesoderm migration and differentiation, Cell, vol.107, pp.387-98, 2001.
, Anaplastic lymphoma kinase spares organ growth during nutrient restriction in Drosophila, Cell, vol.146, pp.435-482, 2011.
, Leukocyte tyrosine kinase functions in pigment cell development, PLoS Genet, vol.4, p.1000026, 2008.
, Anaplastic lymphoma kinase (ALK): structure, oncogenic activation, and pharmacological inhibition, Pharmacol. Res, vol.68, pp.68-94, 2013.
DOI : 10.1016/j.phrs.2012.11.007
, Mechanistic insight into ALK receptor tyrosine kinase in human cancer biology, Nat. Rev. Cancer, vol.13, pp.685-700, 2013.
, Behavioral and neurochemical alterations in mice deficient in anaplastic lymphoma kinase suggest therapeutic potential for psychiatric indications, Neuropsychopharmacology, vol.33, pp.685-700, 2008.
, An adhesive domain detected in functionally diverse receptors, Trends Biochem. Sci, vol.18, pp.40-41, 1993.
, FAM150A and FAM150B are activating ligands for anaplastic lymphoma kinase, Elife, vol.4, p.9811, 2015.
DOI : 10.7554/elife.09811
URL : https://doi.org/10.7554/elife.09811
, J. in Methods Enzymol, vol.548, pp.23-67, 2014.
, Characterization of some molecular mechanisms governing autoactivation of the catalytic domain of the anaplastic lymphoma kinase, J. Biol. Chem, vol.283, pp.3743-50, 2008.
, Unique substrate specificity of anaplastic lymphoma kinase (ALK): development of phosphoacceptor peptides for the assay of ALK activity, Biochemistry, vol.44, pp.8533-8575, 2005.
, Translocations involving anaplastic lymphoma kinase (ALK), Oncogene, vol.20, pp.5623-5660, 2001.
DOI : 10.1038/sj.onc.1204594
URL : https://www.nature.com/articles/1204594.pdf
, How does conformational flexibility influence key structural features involved in activation of anaplastic lymphoma kinase?, Mol. Biosyst, vol.10, pp.1490-1495, 2014.
, Anaplastic lymphoma kinase: role in cancer pathogenesis and smallmolecule inhibitor development for therapy, Expert Rev. Anticancer Ther, vol.9, pp.331-56, 2009.
DOI : 10.1586/14737140.9.3.331
URL : http://europepmc.org/articles/pmc2780428?pdf=render
, Jelly belly protein activates the receptor tyrosine kinase Alk to specify visceral muscle pioneers, Nature, vol.425, pp.507-512, 2003.
, HEN-1, a secretory protein with an LDL receptor motif, regulates sensory integration and learning in Caenorhabditis elegans, Cell, vol.109, pp.639-688, 2002.
, Deorphanization of the human leukocyte tyrosine kinase (LTK) receptor by a signaling screen of the extracellular proteome, Proc. Natl. Acad. Sci. U. S. A, vol.111, pp.15741-15746, 2014.
, Anaplastic lymphoma kinase: signalling in development and disease, Biochem. J, vol.420, pp.345-61, 2009.
DOI : 10.1042/bj20090387
URL : http://www.biochemj.org/content/420/3/345.full.pdf
, Heparin is an activating ligand of the orphan receptor tyrosine kinase ALK, Sci. Signal, vol.8, p.6, 2015.
, A ligand for ALK. Sci. Signal, vol.8, p.2, 2015.
, ALK is a novel dependence receptor: potential implications in development and cancer, Cell Cycle, vol.6, pp.1533-1541, 2007.
URL : https://hal.archives-ouvertes.fr/inserm-00166091
, Anaplastic lymphoma kinase is a dependence receptor whose proapoptotic functions are activated by caspase cleavage, Mol. Cell. Biol, vol.26, pp.6209-6231, 2006.
URL : https://hal.archives-ouvertes.fr/inserm-00111959
, Characterization of the transforming activity of p80, a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t(2;5), Proc. Natl. Acad. Sci. U. S. A, vol.93, pp.4181-4187, 1996.
, The structure and functions of NPM1/Nucleophsmin/B23, a multifunctional nucleolar acidic protein, J. Biochem, vol.143, pp.441-449, 2008.
, Role of nucleophosmin in embryonic development and tumorigenesis, Nature, vol.437, pp.147-53, 2005.
, Npm1 is a haploinsufficient suppressor of myeloid and lymphoid malignancies in the mouse, Blood, vol.111, pp.3859-62, 2008.
, Determining the contribution of NPM1 heterozygosity to NPM-ALKinduced lymphomagenesis, Lab. Investig, vol.91, pp.1298-1303, 2011.
, Role of the nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis, Mol. Cell. Biol, vol.17, pp.2312-2337, 1997.
, Excess of NPM-ALK oncogenic signaling promotes cellular apoptosis and drug dependency, Oncogene, vol.35, pp.3854-65, 2016.
, TPM3-ALK expression induces changes in cytoskeleton organisation and confers higher metastatic capacities than other ALK fusion proteins, Eur. J. Cancer, vol.43, pp.640-646, 2007.
DOI : 10.1016/j.ejca.2006.12.005
, Differential effects of X-ALK fusion proteins on proliferation, transformation, and invasion properties of NIH3T3 cells, Oncogene, vol.23, pp.6071-82, 2004.
, Conditional TPM3-ALK and NPM-ALK transgenic mice develop reversible ALKpositive early B-cell lymphoma / leukemia, vol.115, pp.4061-4070, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00502987
, The origins of ALK translocations, Front. Biosci. (Schol. Ed), vol.7, pp.260-268, 2015.
, The cellular etiology of chromosome translocations, Curr. Opin. Cell Biol, vol.25, pp.357-64, 2013.
, Gene deregulation and spatial genome reorganization near breakpoints prior to formation of translocations in anaplastic large cell lymphoma, Proc. Natl. Acad. Sci, vol.106, pp.5831-5836, 2009.
, Hyperphosphorylation of a novel 80 kDa protein-tyrosine kinase similar to Ltk in a human Ki-1 lymphoma cell line, AMS3, Oncogene, vol.9, pp.1567-74, 1994.
, Expression, Characterization, and Crystallization of the Catalytic Core of the Human Insulin Receptor Protein-tyrosine Kinase Domain, J. Biol. Chem, vol.270, pp.8122-8130, 1995.
, Lymphomes Anaplasiques à Grandes Cellules ALK positifs : signature pronostique des rechutes précoces, These Dr, vol.1, 2015.
, The Prototypic Member of a Family of Oncogenic Fusion Tyrosine Kinases, J. Signal Transduct, p.123253, 2012.
, The anaplastic lymphoma kinase in the pathogenesis of cancer, Nat. Rev. Cancer, vol.8, pp.11-23, 2008.
, NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors, Blood, vol.101, pp.1919-1946, 2003.
, Multilevel dysregulation of STAT3 activation in anaplastic lymphoma kinasepositive T/null-cell lymphoma, J. Immunol, vol.168, pp.466-74, 2002.
, Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death, Oncogene, vol.21, pp.1038-1085, 2002.
, Differential expression and clinical significance of tyrosine-phosphorylated STAT3 in ALK+ and ALK-anaplastic large cell lymphoma, Clin. Cancer Res, vol.9, pp.3692-3701, 2003.
, Inhibition of ALK enzymatic activity in T-cell lymphoma cells induces apoptosis and suppresses proliferation and STAT3 phosphorylation independently of Jak3, Lab. Invest, vol.85, pp.1544-54, 2005.
, Inhibition of JAK3 induces apoptosis and decreases anaplastic lymphoma kinase activity in anaplastic large cell lymphoma, Oncogene, vol.22, pp.5399-407, 2003.
, STAT1 is phosphorylated and downregulated by the oncogenic tyrosine kinase NPM-ALK in ALK-positive anaplastic large-cell lymphoma, Blood, vol.126, pp.336-381, 2015.
, Jak3 activation is significantly associated with ALK expression in anaplastic large cell lymphoma, Hum. Pathol, vol.36, pp.939-983, 2005.
, The function of Stat3 in tumor cells and their microenvironment, Semin. Cell Dev. Biol, vol.19, pp.341-350, 2008.
, Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target, Nat. Med, vol.11, pp.623-632, 2005.
, Selective inhibition of STAT3 induces apoptosis and G(1) cell cycle arrest in ALK-positive anaplastic large cell lymphoma, Oncogene, vol.23, pp.5426-5460, 2004.
, STAT3 induces transcription of the DNA methyltransferase 1 gene (DNMT1) in malignant T lymphocytes, Blood, vol.108, pp.1058-64, 2006.
, Acetylated STAT3 is crucial for methylation of tumor-suppressor gene promoters and inhibition by resveratrol results in demethylation, Proc. Natl. Acad. Sci. U. S. A, vol.109, pp.7765-7774, 2012.
, STAT5A is epigenetically silenced by the tyrosine kinase NPM1-ALK and acts as a tumor suppressor by reciprocally inhibiting NPM1-ALK expression, Nat. Med, vol.13, pp.1341-1349, 2007.
, Reversal of microRNA-150 silencing disadvantages crizotinibresistant NPM-ALK(+) cell growth, J. Clin. Invest, vol.125, pp.3505-3523, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01614947
, JunB induced by constitutive CD30-extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase signaling activates the CD30 promoter in anaplastic large cell lymphoma and reed-sternberg cells of Hodgkin lymphoma, Cancer Res, vol.65, pp.7628-7662, 2005.
, The oncoprotein NPM-ALK of anaplastic large-cell lymphoma induces JUNB transcription via ERK1/2 and JunB translation via mTOR signaling, Blood, vol.110, pp.3374-83, 2007.
, Oncogenic tyrosine kinase NPM/ALK induces activation of the MEK/ERK signaling pathway independently of c-Raf, Oncogene, vol.26, pp.813-834, 2007.
, Anaplastic large cell lymphoma: twenty-five years of discovery, Arch. Pathol. Lab. Med, vol.135, pp.19-43, 2011.
, NPM-ALK oncogenic kinase promotes cell-cycle progression through activation of JNK/cJun signaling in anaplastic large-cell lymphoma, Blood, vol.110, pp.1621-1651, 2007.
, NPM-ALK and the JunB transcription factor regulate the expression of cytotoxic molecules in ALK-positive, anaplastic large cell lymphoma, Int. J. Clin. Exp. Pathol, vol.4, pp.124-157, 2011.
, Phosphoinositide-specific phospholipase C and mitogenic signaling, Biochim. Biophys. Acta -Rev. Cancer, vol.1242, pp.99-113, 1995.
, Nucleophosmin-anaplastic lymphoma kinase of large-cell anaplastic lymphoma is a constitutively active tyrosine kinase that utilizes phospholipase C-gamma to mediate its mitogenicity, Mol. Cell. Biol, vol.18, pp.6951-61, 1998.
, Nucleophosmin-anaplastic lymphoma kinase of anaplastic large-cell lymphoma recruits, activates, and uses pp60c-src to mediate its mitogenicity, Blood, vol.103, pp.1464-71, 2004.
, pp60c-Src phosphorylates and activates vacuolar protein sorting 34 to mediate cellular transformation, Cancer Res, vol.70, pp.5974-83, 2010.
, Nucleophosmin-anaplastic lymphoma kinase associated with anaplastic largecell lymphoma activates the phosphatidylinositol 3-kinase/Akt antiapoptotic signaling pathway, Blood, vol.96, pp.4319-4346, 2000.
, Role of phosphatidylinositol 3-kinase-Akt pathway in nucleophosmin/anaplastic lymphoma kinase-mediated lymphomagenesis, Cancer Res, vol.61, pp.2194-2203, 2001.
, Apoptosis: Akt is more than just a Bad kinase, Nature, vol.401, pp.33-34, 1999.
, NPM-ALK signals through glycogen synthase kinase 3? to promote oncogenesis, Oncogene, vol.31, pp.3733-3773, 2012.
, NPM-ALK fusion kinase of anaplastic large-cell lymphoma regulates survival and proliferative signaling through modulation of FOXO3a, Blood, vol.103, pp.4622-4631, 2004.
, The expression of CD30 in anaplastic large cell lymphoma is regulated by nucleophosmin-anaplastic lymphoma kinase-mediated JunB level in a cell type-specific manner, Cancer Res, vol.66, pp.9002-9010, 2006.
, Tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lymphomas, Blood, vol.85, pp.3378-404, 1995.
, CD30 activates both the canonical and alternative NF-kappaB pathways in anaplastic large cell lymphoma cells, J. Biol. Chem, vol.282, pp.10252-62, 2007.
, Reappraisal of BCL3 as a molecular marker of anaplastic large cell lymphoma, Int. J. Hematol, vol.82, pp.397-405, 2005.
, The oncogenic JUNB/CD30 axis contributes to cell cycle deregulation in ALK+ anaplastic large cell lymphoma, Br. J. Haematol, vol.167, pp.514-537, 2014.
, The epidemiology and targeted therapies for relapsed and refractory CD30+ lymphomas, Curr. Med. Res. Opin, vol.31, pp.537-582, 2015.
, The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14, Cell, vol.75, pp.843-54, 1993.
URL : https://hal.archives-ouvertes.fr/in2p3-00597159
, Therapeutic targeting of microRNAs: current status and future challenges, Nat. Rev. Drug Discov, vol.13, pp.622-660, 2014.
, Switching from repression to activation: microRNAs can up-regulate translation, Science, vol.318, pp.1931-1935, 2007.
, Cell-cycle control of microRNA-mediated translation regulation, Cell Cycle, vol.7, pp.1545-1554, 2008.
, MicroRNA-10a binds the 5'UTR of ribosomal protein mRNAs and enhances their translation, Mol. Cell, vol.30, pp.460-71, 2008.
, MicroRNA genes are transcribed by RNA polymerase II, EMBO J, vol.23, pp.4051-60, 2004.
, Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs, RNA, vol.10, pp.1957-66, 2004.
, Cell, vol.116, pp.281-297, 2004.
, Biogenesis of small RNAs in animals, Nat. Rev. Mol. Cell Biol, vol.10, pp.126-165, 2009.
, Exportin-5 mediates the nuclear export of premicroRNAs and short hairpin RNAs, Genes Dev, vol.17, pp.3011-3017, 2003.
, Role for a bidentate ribonuclease in the initiation step of RNA interference, Nature, vol.409, pp.363-369, 2001.
, The role of GW182 proteins in miRNA-mediated gene silencing, Adv. Exp. Med. Biol, vol.768, pp.147-63, 2013.
, Small RNA sorting: matchmaking for Argonautes, Nat. Rev. Genet, vol.12, pp.19-31, 2011.
, Composition of seed sequence is a major determinant of microRNA targeting patterns, Bioinformatics, vol.30, pp.1377-83, 2014.
, Revisiting the principles of microRNA target recognition and mode of action, Nat. Rev. Mol. Cell Biol, vol.10, pp.141-149, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00370008
, Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets, Cell, vol.120, pp.15-20, 2005.
, Mechanisms of miRNAMediated Gene Regulation from Common Downregulation to mRNA-Specific Upregulation, Int. J. Genomics, p.970607, 2014.
, New class of microRNA targets containing simultaneous 5'-UTR and 3'-UTR interaction sites, Genome Res, vol.19, pp.1175-83, 2009.
, MicroRNA binding sites in the coding region of mRNAs: extending the repertoire of post-transcriptional gene regulation, Bioessays, vol.36, pp.617-643, 2014.
, The small RNA world, J. Cell Sci, vol.116, pp.4689-93, 2003.
, Transcription and RNA interference in the formation of heterochromatin, Nature, vol.447, pp.399-406, 2007.
, Control of translation and mRNA degradation by miRNAs and siRNAs, Genes Dev, vol.20, pp.515-539, 2006.
, Let-7 microRNA-mediated mRNA deadenylation and translational repression in a mammalian cell-free system, Genes &
, , vol.21, pp.1857-1862, 2007.
, MicroRNA silencing through RISC recruitment of eIF6, Nature, vol.447, pp.823-831, 2007.
, MicroRNA inhibition of translation initiation in vitro by targeting the capbinding complex eIF4F, Science, vol.317, pp.1764-1771, 2007.
, The lin-4 Regulatory RNA Controls Developmental Timing in Caenorhabditis elegans by Blocking LIN-14 Protein Synthesis after the Initiation of Translation, Dev. Biol, vol.216, pp.671-680, 1999.
, The GW182 protein colocalizes with mRNA degradation associated proteins hDcp1 and hLSm4 in cytoplasmic GW bodies, RNA, vol.9, pp.1171-1174, 2003.
, Argonaute 2/RISC resides in sites of mammalian mRNA decay known as cytoplasmic bodies, Nat. Cell Biol, vol.7, pp.633-639, 2005.
, The role of microRNAs in normal and malignant hematopoiesis, Eur. J. Haematol, vol.84, pp.1-16, 2010.
, Hypoxia-microRNA-16 downregulation induces VEGF expression in anaplastic lymphoma kinase (ALK)-positive anaplastic large-cell lymphomas, Leukemia, vol.25, pp.1882-90, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00611903
, MiR-29a down-regulation in ALK-positive anaplastic large cell lymphomas contributes to apoptosis blockade through MCL-1 overexpression, Blood, vol.117, pp.6627-6664, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00611908
, MicroRNA expression profiling identifies molecular signatures associated with anaplastic large cell lymphoma, Blood, vol.122, pp.2083-92, 2013.
, Identification of differential and functionally active miRNAs in both anaplastic lymphoma kinase (ALK)+ and ALK-anaplastic large-cell lymphoma, Proc. Natl. Acad. Sci. U. S. A, vol.107, pp.16228-16261, 2010.
, STAT3-mediated activation of microRNA cluster 17~92 promotes proliferation and survival of ALK-positive anaplastic large cell lymphoma, Haematologica, vol.99, pp.116-140, 2014.
, MicroRNA 96 is a post-transcriptional suppressor of anaplastic lymphoma kinase expression, Am. J. Pathol, vol.180, pp.1772-80, 2012.
, Challenges and opportunities of microRNAs in lymphomas, Molecules, vol.19, pp.14723-81, 2014.
, Identification of differential and functionally active miRNAs in both anaplastic lymphoma kinase ( ALK ) + and ALK ? anaplastic large-cell lymphoma, 2010.
, MicroRNA expression profiling identifies molecular signatures associated with anaplastic large cell lymphoma, Blood, vol.122, pp.2083-92, 2013.
, Next-Generation Sequencing Identifies Deregulation of MicroRNAs Involved in Both Innate and Adaptive Immune Response in ALK+ ALCL, PLoS One, vol.10, p.117780, 2015.
, The Three Paralogous MicroRNA Clusters in Development and Disease, Cairo), vol.2016, pp.1-10, 2016.
, Next-Generation Sequencing Identifies Deregulation of MicroRNAs Involved in Both Innate and Adaptive Immune Response in ALK+ ALCL, PLoS One, vol.10, p.117780, 2015.
, A microRNA polycistron as a potential human oncogene, Nature, vol.435, pp.828-861, 2005.
, miRiad roles for the miR-17-92 cluster in development and disease, Cell, vol.133, pp.217-239, 2008.
, Interleukin-6 modulates the expression of the bone morphogenic protein receptor type II through a novel STAT3-microRNA cluster 17/92 pathway, Circ. Res, vol.104, pp.1184-91, 2009.
, NPM-ALK oncogenic tyrosine kinase controls T-cell identity by transcriptional regulation and epigenetic silencing in lymphoma cells, Cancer Res, vol.69, pp.8611-8620, 2009.
, MicroRNA-106a targets autophagy and enhances sensitivity of lung cancer cells to Src inhibitors, Lung Cancer, 2016.
, MiR-20a and miR-106b negatively regulate autophagy induced by leucine deprivation via suppression of ULK1 expression in C2C12 myoblasts, Cell. Signal, vol.24, pp.2179-86, 2012.
, MicroRNA and ALK-positive anaplastic large cell lymphoma, Front. Biosci. (Schol. Ed), vol.7, pp.217-242, 2015.
, Oncogenic role of miR-155 in anaplastic large cell lymphoma lacking the t(2;5) translocation, J. Pathol, vol.236, pp.445-456, 2015.
, MicroRNA expression in lymphocyte development and malignancy, Leukemia, vol.22, pp.1440-1446, 2008.
, MiR-26a Inhibits Proliferation and Migration of Breast Cancer through Repression of MCL-1, PLoS One, vol.8, p.65138, 2013.
, NPM-ALK up-regulates iNOS expression through a STAT3/microRNA-26a-dependent mechanism, J. Pathol, vol.230, pp.82-94, 2013.
, MicroRNA-150 inhibits tumor invasion and metastasis by targeting the chemokine receptor CCR6, in advanced cutaneous T-cell lymphoma, Blood, vol.123, pp.1499-511, 2014.
, Antineoplastic activity of the DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine in anaplastic large cell lymphoma, Biochimie, vol.94, pp.2297-307, 2012.
, The STAT3-DNMT1 connection, JAK-STAT, vol.1, pp.257-60, 2012.
, IL-2R common gamma-chain is epigenetically silenced by nucleophosphinanaplastic lymphoma kinase (NPM-ALK) and acts as a tumor suppressor by targeting NPM-ALK, Proc. Natl. Acad. Sci. U. S. A, vol.108, pp.11977-82, 2011.
, Oncogenic tyrosine kinase NPM-ALK induces expression of the growthpromoting receptor ICOS, Blood, vol.118, pp.3062-71, 2011.
, Crizotinib in Anaplastic Large-Cell Lymphoma, N. Engl. J. Med, vol.364, pp.775-776, 2011.
,
, Bull. Cancer, vol.93, pp.1191-1200, 2006.
, Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma, N. Engl. J. Med, vol.328, pp.1002-1008, 1993.
, Antinéoplasiques Immunomodulateurs, 2007.
, Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group, Blood, vol.116, pp.3418-3443, 2010.
, Long-term outcome of adults with systemic anaplastic large-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte trials, J. Clin. Oncol, vol.30, pp.3939-3985, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00766851
, ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes, Blood, vol.124, pp.1473-80, 2014.
, Upfront VIP-reinforced-ABVD (VIP-rABVD) is not superior to CHOP/21 in newly diagnosed peripheral T cell lymphoma. Results of the randomized phase III trial GOELAMS-LTP95, Br. J. Haematol, vol.151, pp.159-66, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00569409
, Long-term follow-up of patients with peripheral T-cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantation, Leukemia, vol.20, pp.1533-1541, 2006.
, Impact of the methotrexate administration dose on the need for intrathecal treatment in children and adolescents with anaplastic large-cell lymphoma: results of a randomized trial of the EICNHL Group, J. Clin. Oncol, vol.27, pp.897-903, 2009.
, Vinblastine in children and adolescents with high-risk anaplastic largecell lymphoma: results of the randomized ALCL99-vinblastine trial, J. Clin. Oncol, vol.28, pp.3987-93, 2010.
, Relapsed or refractory anaplastic large-cell lymphoma in children and adolescents after Berlin-Frankfurt-Muenster (BFM)-type first-line therapy: a BFM-group study, J. Clin. Oncol, vol.29, pp.3065-71, 2011.
, Peripheral T-cell lymphoma: the role of hematopoietic stem cell transplantation, Crit. Rev. Oncol. Hematol, vol.89, pp.248-61, 2014.
, Hematopoietic cell transplantation for systemic mature T-cell non-Hodgkin lymphoma, J. Clin. Oncol, vol.31, pp.3100-3109, 2013.
, Autologous stem cell transplant for relapsed and refractory peripheral T-cell lymphoma: variable outcome according to pathological subtype, Br. J. Haematol, vol.120, pp.978-85, 2003.
, Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cells, J. Clin. Oncol, vol.22, pp.2172-2178, 2004.
, Survival of patients with peripheral T-cell lymphoma after first relapse or progression: spectrum of disease and rare long-term survivors, J. Clin. Oncol, vol.31, pp.1970-1976, 2013.
, Single-drug vinblastine as salvage treatment for refractory or relapsed anaplastic large-cell lymphoma: a report from the French Society of Pediatric Oncology, J. Clin. Oncol, vol.27, pp.5056-61, 2009.
, Hematopoietic stem cell transplantation in relapsed ALK+ anaplastic large cell lymphoma in children and adolescents: a study on behalf of the SFCE and SFGM-TC, Bone Marrow Transplant, vol.50, pp.795-801, 2015.
, Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal-Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK), 2011.
, How does conformational flexibility influence key structural features involved in activation of anaplastic lymphoma kinase?, Mol. BioSyst. Mol. BioSyst, vol.10, pp.1490-1495, 2014.
, Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma, Mol. Cancer Ther, vol.6, pp.3314-3336, 2007.
, Genomic alterations of anaplastic lymphoma kinase may sensitize tumors to anaplastic lymphoma kinase inhibitors, Cancer Res, vol.68, pp.3389-95, 2008.
, Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Ann. Oncol, vol.23, issue.7, pp.56-64, 2012.
, First-Line Crizotinib versus Chemotherapy in ALK -Positive Lung Cancer, N. Engl. J. Med, vol.371, pp.2167-2177, 2014.
, Chemoresistant ALK+ Lymphoma Patients. Blood, vol.116, pp.2877-2877, 2010.
, Crizotinib as salvage and maintenance with allogeneic stem cell transplantation for refractory anaplastic large cell lymphoma, J. Natl. Compr. Canc. Netw, vol.12, p.326, 2014.
, Editor in Chief: Response to Eyre et al. "ALK-positive anaplastic large cell lymphoma: current and future perspectives in adult and paediatric disease", Eur. J. Haematol, vol.94, pp.86-93, 2015.
, Crizotinib in advanced, chemoresistant anaplastic lymphoma kinase-positive lymphoma patients, J. Natl. Cancer Inst, vol.106, p.378, 2014.
, Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study, Lancet. Oncol, vol.14, pp.472-80, 2013.
, Abrupt Relapse of ALK-Positive Lymphoma after Discontinuation of Crizotinib, n engl j med Proc Natl Acad Sci U S A, vol.3741, pp.2657-64, 2016.
, Mechanisms of resistance to crizotinib in patients with ALK gene rearranged non-small cell lung cancer, Clin. Cancer Res, vol.18, pp.1472-82, 2012.
, Anaplastic lymphoma kinase (ALK) fusion oncogene positive non-small cell lung cancer, 2016.
, Second-and third-generation ALK inhibitors for non-small cell lung cancer, J. Hematol. Oncol, vol.9, p.19, 2016.
, ALK inhibitors in non-small cell lung cancer: the latest evidence and developments, Ther. Adv. Med. Oncol, vol.8, pp.32-47, 2016.
, Evidence Suggesting That Discontinuous Dosing of ALK Kinase Inhibitors May Prolong Control of ALK+ Tumors, Cancer Res, vol.75, pp.2916-2943, 2015.
, Crizotinib: A comprehensive review, South Asian J. cancer, vol.2, pp.91-98, 2013.
, Mechanisms of acquired crizotinib resistance in ALK-rearranged lung Cancers, Sci. Transl. Med, vol.4, pp.120-137, 2012.
, A novel ALK secondary mutation and EGFR signaling cause resistance to ALK kinase inhibitors, Cancer Res, vol.71, pp.6051-60, 2011.
, EML4-ALK mutations in lung cancer that confer resistance to ALK inhibitors, N. Engl. J. Med, vol.363, pp.1734-1743, 2010.
, Heterogeneity of Genetic Changes Associated with Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancer, J. Thorac. Oncol, vol.8, pp.415-422, 2013.
, Crizotinibresistant NPM-ALK mutants confer differential sensitivity to unrelated Alk inhibitors, Mol. Cancer Res, vol.11, pp.122-154, 2013.
, Activating mutations in ALK kinase domain confer resistance to structurally unrelated ALK inhibitors in NPM-ALK-positive anaplastic large-cell lymphoma, J. Cancer Res. Clin. Oncol, vol.140, pp.589-98, 2014.
, Development of anaplastic lymphoma kinase (ALK) inhibitors and molecular diagnosis in ALK rearrangement-positive lung cancer, Onco. Targets. Ther, vol.7, pp.375-85, 2014.
, Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia, Cancer Cell, vol.2, pp.117-125, 2002.
, EGFR mutation and resistance of non-small-cell lung cancer to gefitinib, N. Engl. J. Med, vol.352, pp.786-92, 2005.
, ALK Kinase Domain Mutations in Primary Anaplastic Large Cell Lymphoma: Consequences on NPM-ALK Activity and Sensitivity to Tyrosine Kinase Inhibitors, PLoS One, vol.10, 2015.
, Treating ALK-positive lung cancer-early successes and future challenges, Nat. Rev. Clin. Oncol, vol.9, pp.268-277, 2012.
, Treatment Efficacy and Resistance Mechanisms Using the SecondGeneration ALK Inhibitor AP26113 in Human NPM-ALK-Positive Anaplastic Large Cell Lymphoma, Mol. Cancer Res, vol.13, pp.775-83, 2015.
, Drug Resistance Mechanisms in Non-Small Cell Lung Carcinoma, J. Can. Res. Updates, vol.2, pp.265-282, 2013.
, Design and synthesis of a highly selective, orally active and potent anaplastic lymphoma kinase inhibitor (CH5424802), Bioorg. Med. Chem, vol.20, pp.1271-1280, 2012.
, CH5424802, a Selective ALK Inhibitor Capable of Blocking the Resistant Gatekeeper Mutant, Cancer Cell, vol.19, pp.679-690, 2011.
, CH5424802 (RO5424802) for patients with ALK-rearranged advanced non-smallcell lung cancer (AF-001JP study): a single-arm, open-label, phase 1-2 study, Lancet Oncol, vol.14, pp.590-598, 2013.
, Insights into brain metastasis in patients with ALK+ lung cancer: is the brain truly a sanctuary?, Cancer Metastasis Rev, vol.34, pp.797-805, 2015.
, Ceritinib: first global approval, Drugs, vol.74, pp.1285-91, 2014.
, The ALK inhibitor ceritinib overcomes crizotinib resistance in non-small cell lung cancer, Cancer Discov, vol.4, pp.662-73, 2014.
, Synthesis, Structure-Activity Relationships, and in Vivo Efficacy of the Novel Potent and Selective Anaplastic Lymphoma Kinase (ALK) Inhibitor 5-Chloro-N2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N4-(2-(isopropylsulf onyl)phenyl)pyrimidine-2,4-dia, J Med Chem, vol.56, pp.5675-5690, 2013.
, CERITINIB (LDK378) FOR TREATMENT OF PATIENTS WITH ALK-REARRANGED (ALK+) NON-SMALL CELL LUNG CANCER (NSCLC) AND BRAIN METASTASES (BM) IN THE ASCEND-1 TRIAL, Neuro. Oncol, vol.16, pp.39-39, 2014.
, AP26113, a potent ALK inhibitor, overcomes mutations in EML4-ALK that confer resistance to PF-02341066 (PF1066): Cancer Res, vol.70, 2010.
, AP26113 possesses pan-inhibitory activity versus crizotinib-resistant ALK mutants and oncogenic ROS1 fusions, Cancer Res, vol.73, pp.5655-5655, 2013.
, AP26113 is a dual ALK/EGFR inhibitor: Characterization against EGFR T790M in cell and mouse models of NSCLC, Cancer Res, vol.72, pp.1794-1794, 2012.
, Safety and efficacy of brigatinib (AP26113) in advanced malignancies, including ALK+ non-small cell lung cancer (NSCLC), ASCO Meet. Abstr, vol.33, p.8062, 2015.
, Resensitization to Crizotinib by the Lorlatinib ALK Resistance Mutation L1198F, 2016.
, The ALK inhibitor ASP3026 eradicates NPM-ALK + T-cell anaplastic large-cell lymphoma in vitro and in a systemic xenograft lymphoma model, Oncotarget, vol.5, pp.5750-63, 2014.
, CD4 T-helper responses to the anaplastic lymphoma kinase (ALK) protein in patients with ALK-positive anaplastic large-cell lymphoma, Cancer Res, vol.67, pp.1898-901, 2007.
, B and CTL responses to the ALK protein in patients with ALK-positive ALCL, Int. J. cancer, vol.118, pp.688-95, 2006.
, Immune response to the ALK oncogenic tyrosine kinase in patients with anaplastic large-cell lymphoma, Blood, vol.96, pp.1605-1612, 2000.
, Correlation of the autoantibody response to the ALK oncoantigen in pediatric anaplastic lymphoma kinase-positive anaplastic large cell lymphoma with tumor dissemination and relapse risk, Blood, vol.115, pp.3314-3323, 2010.
, Use of minimal disseminated disease and immunity to NPM-ALK antigen to stratify ALK-positive ALCL patients with different prognosis, Leukemia, vol.27, pp.416-438, 2013.
, Kinetics of humoral response to ALK and its relationship with minimal residual disease in pediatric ALCL, Leukemia, vol.23, pp.400-402, 2009.
, ALK as a novel lymphoma-associated tumor antigen: identification of 2 HLA-A2.1-restricted CD8+ T-cell epitopes, Blood, vol.99, pp.2100-2106, 2002.
, The anaplastic lymphoma kinase is an effective oncoantigen for lymphoma vaccination, Nat. Med, vol.14, pp.676-680, 2008.
, Phase I/II study of an anti-CD30 monoclonal antibody (MDX-060) in Hodgkin's lymphoma and anaplastic large-cell lymphoma, J. Clin. Oncol, vol.25, pp.2764-2773, 2007.
, A Phase II study of SGN-30 (anti-CD30 mAb) in Hodgkin lymphoma or systemic anaplastic large cell lymphoma, Br. J. Haematol, vol.146, pp.171-180, 2009.
, Brentuximab Vedotin (SGN-35), Clin. Cancer Res, vol.17, pp.6428-6464, 2011.
DOI : 10.1158/1078-0432.ccr-11-0488
URL : http://clincancerres.aacrjournals.org/content/17/20/6428.full.pdf
, The discovery and development of brentuximab vedotin for use in relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma, Nat. Biotechnol, vol.30, pp.631-637, 2012.
, cAC10-vcMMAE, an anti-CD30-monomethyl auristatin E conjugate with potent and selective antitumor activity, Blood, vol.102, pp.1458-65, 2003.
, Effects of drug loading on the antitumor activity of a monoclonal antibody drug conjugate, Clin. Cancer Res, vol.10, pp.7063-70, 2004.
, Brentuximab Vedotin (SGN-35) for Relapsed CD30-Positive Lymphomas, 2010.
, Brentuximab vedotin (SGN-35) in patients with relapsed or refractory systemic anaplastic large-cell lymphoma: results of a phase II study, J. Clin. Oncol, vol.30, pp.2190-2196, 2012.
, Hsp90: structure and function, Top. Curr. Chem, vol.328, pp.155-240, 2013.
, Nucleophosmin-anaplastic lymphoma kinase (NPM-ALK), a novel Hsp90-client tyrosine kinase: down-regulation of NPM-ALK expression and tyrosine phosphorylation in ALK(+) CD30(+) lymphoma cells by the Hsp90 antagonist 17-allylamino,17-demethoxygeldanamycin, Cancer Res, vol.62, pp.1559-66, 2002.
, Ubiquitination and proteasomal degradation of nucleophosmin-anaplastic lymphoma kinase induced by 17-allylaminodemethoxygeldanamycin: role of the co-chaperone carboxyl heat shock protein 70-interacting protein, Cancer Res, vol.64, pp.3256-64, 2004.
, The HSP90 inhibitor 17-AAG synergizes with doxorubicin and U0126 in anaplastic large cell lymphoma irrespective of ALK expression, Exp. Hematol, vol.34, pp.1670-1679, 2006.
, Targeted inhibition of the molecular chaperone Hsp90 overcomes ALK inhibitor resistance in non-small cell lung cancer, Cancer Discov, vol.3, pp.430-473, 2013.
, Adult systemic anaplastic large-cell lymphoma: recommendations for diagnosis and management, Expert Rev. Hematol, vol.9, pp.137-50, 2016.
, Emerging regulation and functions of autophagy, Nat. Cell Biol, vol.15, pp.713-720, 2013.
, Participation of lysosomes in cellular autophagy induced in rat liver by glucagon, J. Cell Biol, vol.35, pp.11-17, 1967.
, Influence of glucagon, an inducer of cellular autophagy, on some physical properties of rat liver lysosomes, J. Cell Biol, vol.33, pp.437-486, 1967.
, Autophagy: process and function, Genes Dev, vol.21, pp.2861-2873, 2007.
, Autophagy Mechanism, Regulation, Functions, and Disorders, ISRN Cell Biol, vol.2012, pp.1-11, 2012.
, Autophagy in Human Health and Disease, N. Engl. J. Med, vol.368, pp.651-662, 2013.
, Autophagy and human diseases, Cell Res, vol.24, pp.69-79, 2014.
, Microautophagy: lesser-known self-eating, Cell. Mol. Life Sci, vol.69, pp.1125-1161, 2012.
, Quantitative correlation between proteolysis and macro-and microautophagy in mouse hepatocytes during starvation and refeeding, Proc. Natl. Acad. Sci. U. S. A, vol.80, pp.2179-83, 1983.
, Microautophagy in mammalian cells: Revisiting a 40-year-old conundrum, Autophagy, vol.7, pp.673-682, 2011.
, Chaperone-mediated autophagy: a unique way to enter the lysosome world, Trends Cell Biol, vol.22, pp.407-424, 2012.
DOI : 10.1016/j.tcb.2012.05.006
URL : http://europepmc.org/articles/pmc3408550?pdf=render
, Chaperone-mediated autophagy, Proc. Am. Thorac. Soc, vol.7, pp.29-39, 2010.
, Peptide sequences that target cytosolic proteins for lysosomal proteolysis, Trends Biochem. Sci, vol.15, pp.305-314, 1990.
, A Receptor for the Selective Uptake and Degradation of Proteins by Lysosomes. Science (80-. ), vol.273, pp.501-503, 1996.
, Activation of a selective pathway of lysosomal proteolysis in rat liver by prolonged starvation, Am. J. Physiol, vol.269, pp.1200-1208, 1995.
, Activation of chaperone-mediated autophagy during oxidative stress, Mol. Biol. Cell, vol.15, pp.4829-4869, 2004.
DOI : 10.1091/mbc.e04-06-0477
URL : http://europepmc.org/articles/pmc524731?pdf=render
, Manipulating autophagic processes in autoimmune diseases: a special focus on modulating chaperone-mediated autophagy, an emerging therapeutic target, Front. Immunol, vol.6, 2015.
, Chaperone-mediated autophagy regulates proliferation by targeting RND3 in gastric cancer, Autophagy, vol.12, pp.515-543, 2016.
DOI : 10.1080/15548627.2015.1136770
URL : http://europepmc.org/articles/pmc4836009?pdf=render
, Chaperone-mediated autophagy is required for tumor growth, Sci. Transl. Med, vol.3, pp.109-117, 2011.
DOI : 10.1126/scitranslmed.3003182
URL : http://europepmc.org/articles/pmc4000261?pdf=render
, Acetylation targets the M2 isoform of pyruvate kinase for degradation through chaperone-mediated autophagy and promotes tumor growth, Mol. Cell, vol.42, pp.719-749, 2011.
, LAMP2A overexpression in breast tumors promotes cancer cell survival via chaperone-mediated autophagy, Autophagy, vol.8, pp.1643-56, 2012.
, Eating the strangers within: host control of intracellular bacteria via xenophagy, Cell. Microbiol, vol.13, pp.1319-1346, 2011.
, Methods in mammalian autophagy research, Cell, vol.140, pp.313-326, 2010.
, Autophagic lysosome reformation, Exp. Cell Res, vol.319, pp.142-146, 2013.
DOI : 10.1016/j.yexcr.2012.09.004
, Termination of autophagy and reformation of lysosomes regulated by mTOR, Nature, vol.465, pp.942-946, 2010.
, p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death, J. Cell Biol, vol.171, pp.603-617, 2005.
, Etude de la régulation de l ' autophagie au cours de la différenciation des cellules de leucémie aiguë promyélocytaire : rôles dans la survie et la différenciation cellulaire, 2013.
, Organellophagy: eliminating cellular building blocks via selective autophagy, J. Cell Biol, vol.205, pp.435-480, 2014.
, Selective autophagy. Essays Biochem, vol.55, pp.79-92, 2013.
, Omegasomes: PI3P platforms that manufacture autophagosomes, Essays Biochem, vol.55, pp.17-27, 2013.
, p62/SQSTM1: a missing link between protein aggregates and the autophagy machinery, Autophagy, vol.2, pp.138-147
, The role of the selective adaptor p62 and ubiquitin-like proteins in autophagy, Biomed Res. Int, p.832704, 2014.
, Autophagic degradation of the BCR-ABL oncoprotein and generation of antileukemic responses by arsenic trioxide, Blood, vol.120, pp.3555-62, 2012.
, Autophagy and regulation of cilia function and assembly, Cell Death Differ, vol.22, pp.389-397, 2015.
, Selective autophagy: Lysophagy. Methods, vol.75, pp.128-132, 2015.
, Isolation and characterization of autophagy-defective mutants of Saccharomyces cerevisiae, FEBS Lett, vol.333, pp.169-74, 1993.
, The autophagosome: origins unknown, biogenesis complex, Nat. Rev. Mol. Cell Biol, vol.14, pp.759-774, 2013.
, WIPI proteins: essential PtdIns3P effectors at the nascent autophagosome, J. Cell Sci, vol.128, pp.207-224, 2015.
, Membrane dynamics in autophagosome biogenesis, J. Cell Sci, vol.128, pp.193-205, 2015.
, ER-mitochondria contacts as sites of mitophagosome formation, Autophagy, vol.10, pp.1346-1353, 2014.
, ER exit sites are physical and functional core autophagosome biogenesis components, Mol. Biol. Cell, vol.24, pp.2918-2949, 2013.
, The ER-Golgi intermediate compartment (ERGIC): in search of its identity and function, J. Cell Sci, vol.119, pp.2173-2183, 2006.
, Exit from the Golgi Is Required for the Expansion of the Autophagosomal Phagophore in Yeast Saccharomyces cerevisiae, Mol. Biol. Cell, vol.21, pp.2270-2284, 2010.
, Plasma membrane contributes to the formation of pre-autophagosomal structures, Nat. Cell Biol, vol.12, pp.747-57, 2010.
, Diverse autophagosome membrane sources coalesce in recycling endosomes, Cell, vol.154, pp.1285-99, 2013.
, Ultrastructural relationship of the phagophore with surrounding organelles, Autophagy, vol.11, pp.439-51, 2015.
, Autophagy initiation by ULK complex assembly on ER tubulovesicular regions marked by ATG9 vesicles, Nat. Commun, vol.7, p.12420, 2016.
, The requirement of uncoordinated 51-like kinase 1 (ULK1) and ULK2 in the regulation of autophagy, Autophagy, vol.7, pp.689-95, 2011.
, The ULK1 complex: sensing nutrient signals for autophagy activation, Autophagy, vol.9, pp.124-161, 2013.
, ULK1.ATG13.FIP200 complex mediates mTOR signaling and is essential for autophagy, J. Biol. Chem, vol.284, pp.12297-305, 2009.
, AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1, Nat. Cell Biol, vol.13, pp.132-173, 2011.
, The Beclin 1-VPS34 complex--at the crossroads of autophagy and beyond, Trends Cell Biol, vol.20, pp.355-62, 2010.
, Atg1 family kinases in autophagy initiation, Cell. Mol. Life Sci, vol.72, pp.3083-96, 2015.
, ULK1 induces autophagy by phosphorylating Beclin-1 and activating VPS34 lipid kinase, Nat. Cell Biol, vol.15, pp.741-750, 2013.
, Regulation of autophagy by phosphatidylinositol 3-phosphate, FEBS Lett, vol.584, pp.1302-1314, 2010.
, Identification of Barkor as a mammalian autophagy-specific factor for Beclin 1 and class III phosphatidylinositol 3-kinase, Proc. Natl. Acad. Sci. U. S. A, vol.105, pp.19211-19217, 2008.
, Two Beclin 1-binding proteins, Atg14L and Rubicon, reciprocally regulate autophagy at different stages, Nat. Cell Biol, vol.11, pp.385-396, 2009.
, Beclin 1 forms two distinct phosphatidylinositol 3-kinase complexes with mammalian Atg14 and UVRAG, Mol. Biol. Cell, vol.19, pp.5360-72, 2008.
, Bif-1 interacts with Beclin 1 through UVRAG and regulates autophagy and tumorigenesis, Nat. Cell Biol, vol.9, pp.1142-51, 2007.
, BECLIN 1-VPS34 COMPLEX ARCHITECTURE: UNDERSTANDING THE NUTS AND BOLTS OF THERAPEUTIC TARGETS, Front. Biol. (Beijing), vol.10, pp.398-426, 2015.
, Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy, Cell, vol.122, pp.927-966, 2005.
, Role of the Apg12 conjugation system in mammalian autophagy, Int. J. Biochem. Cell Biol, vol.35, pp.553-61, 2003.
, The Atg8 and Atg12 ubiquitin-like conjugation systems in macroautophagy, EMBO Rep, vol.9, pp.859-64, 2008.
, Human light chain 3/MAP1LC3B is cleaved at its carboxylterminal Met121 to expose Gly120 for lipidation and targeting to autophagosomal membranes, J. Biol. Chem, vol.279, pp.47704-47714, 2004.
, LC3 conjugation system in mammalian autophagy, Int. J. Biochem. Cell Biol, vol.36, pp.2503-2521, 2004.
, LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing, EMBO J, vol.19, pp.5720-5728, 2000.
, Guidelines for the use and interpretation of assays for monitoring autophagy, Autophagy, vol.12, pp.1-222, 2016.
URL : https://hal.archives-ouvertes.fr/hal-00735751
, The itinerary of autophagosomes: from peripheral formation to kiss-and-run fusion with lysosomes, Traffic, vol.9, pp.574-87, 2008.
, Maturation of autophagosomes and endosomes: A key role for Rab7, Biochim. Biophys. Acta -Mol. Cell Res, vol.1833, pp.503-510, 2013.
, The role of ESCRT proteins in fusion events involving lysosomes, endosomes and autophagosomes, Biochem. Soc. Trans, vol.38, pp.1469-73, 2010.
, Connections between SNAREs and autophagy. Trends Biochem. Sci, vol.38, pp.57-63, 2013.
, Role of LAMP-2 in lysosome biogenesis and autophagy, Mol. Biol. Cell, vol.13, pp.3355-68, 2002.
, Dual roles of Atg8-PE deconjugation by Atg4 in autophagy, Autophagy, vol.8, pp.883-92, 2012.
, Autophagic lysosome reformation, Exp. Cell Res, vol.319, pp.142-148, 2013.
, Canonical and non-canonical autophagy: variations on a common theme of self-eating?, Nat. Rev. Mol. Cell Biol, vol.13, pp.7-12, 2012.
, Role of non-canonical Beclin 1-independent autophagy in cell death induced by resveratrol in human breast cancer cells, Cell Death Differ, vol.15, pp.1318-1347, 2008.
, Functions of lysosomes, Annu. Rev. Physiol, vol.28, pp.435-92, 1966.
, Autophagy regulates endothelial cell processing, maturation and secretion of von Willebrand factor, Nat. Med, vol.19, pp.1281-1288, 2013.
, Monitoring autophagy by electron microscopy in Mammalian cells, Methods Enzymol, vol.452, pp.143-64, 2009.
, Chapter 4 Assaying of Autophagic Protein Degradation, Methods Enzymol, vol.451, 2009.
, Sorting cells for basal and induced autophagic flux by quantitative ratiometric flow cytometry, Autophagy, vol.10, pp.1327-1361, 2014.
, p62/SQSTM1 Binds Directly to Atg8/LC3 to Facilitate Degradation of Ubiquitinated Protein Aggregates by Autophagy, J. Biol. Chem, vol.282, pp.24131-24145, 2007.
, Dissecting the dynamic turnover of GFP-LC3 in the autolysosome, Autophagy, vol.7, pp.188-204, 2011.
, Monodansylcadaverine (MDC) is a specific in vivo marker for autophagic vacuoles, Eur. J. Cell Biol, vol.66, pp.3-14, 1995.
, A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles, Cancer Res, vol.61, pp.439-483, 2001.
, Role and regulation of starvation-induced autophagy in the Drosophila fat body, Dev. Cell, vol.7, pp.167-78, 2004.
, The return of the nucleus: transcriptional and epigenetic control of autophagy, Nat. Rev. Mol. Cell Biol, vol.15, pp.65-74, 2014.
, Autophagy biomarkers in CSF correlates with infarct size, clinical severity and neurological outcome in AIS patients, J. Transl. Med, vol.13, p.359, 2015.
, The core autophagy protein ATG4B is a potential biomarker and therapeutic target in CML stem/progenitor cells, Blood, vol.123, pp.3622-3656, 2014.
, Immunohistochemical detection of cytoplasmic LC3 puncta in human cancer specimens, Autophagy, vol.8, pp.1175-84, 2012.
, Reliable LC3 and p62 autophagy marker detection in formalin fixed paraffin embedded human tissue by immunohistochemistry, Eur. J. Histochem, vol.59, p.2481, 2015.
, Identification of secreted proteins that reflect autophagy dynamics within tumor cells, Autophagy, vol.11, pp.60-74, 2015.
DOI : 10.4161/15548627.2014.984273
URL : https://www.tandfonline.com/doi/pdf/10.4161/15548627.2014.984273?needAccess=true
, Oxidative stress induces autophagy in response to multiple noxious stimuli in retinal ganglion cells, Autophagy, vol.10, pp.1692-701, 2014.
, Autophagy and the integrated stress response, Mol. Cell, vol.40, pp.280-93, 2010.
DOI : 10.1016/j.molcel.2010.09.023
URL : https://doi.org/10.1016/j.molcel.2010.09.023
, Stress management by autophagy: Implications for chemoresistance, Int. J. Cancer, vol.139, pp.23-32, 2016.
DOI : 10.1002/ijc.29990
, MicroRNA regulation of autophagy, Carcinogenesis, vol.33, pp.2018-2043, 2012.
DOI : 10.1093/carcin/bgs266
URL : https://academic.oup.com/carcin/article-pdf/33/11/2018/7461325/bgs266.pdf
, The RNA-binding protein HuD regulates autophagosome formation in pancreatic ? cells by promoting autophagy-related gene 5 expression, J. Biol. Chem, vol.289, pp.112-133, 2014.
, Overexpression of RBM5 induces autophagy in human lung adenocarcinoma cells, World J. Surg. Oncol, vol.14, p.57, 2016.
, mTOR signaling in growth control and disease, Cell, vol.149, pp.274-93, 2012.
DOI : 10.1016/j.cell.2012.03.017
URL : https://doi.org/10.1016/j.cell.2012.03.017
, mTOR regulation of autophagy. FEBS Lett, vol.584, pp.1287-95, 2010.
, mTOR: a pharmacologic target for autophagy regulation, J. Clin. Invest, vol.125, pp.25-32, 2015.
DOI : 10.1172/jci73939
URL : http://www.jci.org/articles/view/73939/files/pdf
, mTOR and cancer: insights into a complex relationship, Nat. Rev. Cancer, vol.6, pp.729-734, 2006.
DOI : 10.1038/nrc1974
, mTOR signaling at a glance, J. Cell Sci, vol.122, pp.3589-94, 2009.
DOI : 10.1242/jcs.051011
URL : http://jcs.biologists.org/content/122/20/3589.full.pdf
, Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress, Mol. Cell, vol.40, pp.310-332, 2010.
, The biology of hypoxia: the role of oxygen sensing in development, normal function, and disease, Genes Dev, vol.18, pp.2183-2194, 2004.
, Mammalian TOR: a homeostatic ATP sensor, Science, vol.294, pp.1102-1107, 2001.
DOI : 10.1126/science.1063518
, Mechanisms of amino acid sensing in mTOR signaling pathway, Nutr. Res. Pract, vol.3, pp.64-71, 2009.
, The tuberous sclerosis complex, Ann. N. Y. Acad. Sci, vol.1184, pp.87-105, 2010.
DOI : 10.1111/j.1749-6632.2009.05117.x
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2892799
, Rheb binds and regulates the mTOR kinase, Curr. Biol, vol.15, pp.702-715, 2005.
DOI : 10.1016/j.cub.2005.02.053
URL : https://doi.org/10.1016/j.cub.2005.02.053
, PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase, Mol. Cell, vol.25, pp.903-918, 2007.
, TSC2 mediates cellular energy response to control cell growth and survival, Cell, vol.115, pp.577-90, 2003.
, Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb, Curr. Biol, vol.13, pp.1259-68, 2003.
, TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling, Nat. Cell Biol, vol.4, pp.648-57, 2002.
, Molecular mechanisms of mTOR-mediated translational control, Nat. Rev. Mol. Cell Biol, vol.10, pp.307-325, 2009.
, PRAS40 regulates mTORC1 kinase activity by functioning as a direct inhibitor of substrate binding, J. Biol. Chem, vol.282, pp.20036-20080, 2007.
, AMPK--sensing energy while talking to other signaling pathways, Cell Metab, vol.20, pp.939-52, 2014.
, AMPK phosphorylation of raptor mediates a metabolic checkpoint, Mol. Cell, vol.30, pp.214-240, 2008.
, Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex, Genes Dev, vol.18, pp.2893-904, 2004.
, Amino acids mediate mTOR/raptor signaling through activation of class 3 phosphatidylinositol 3OH-kinase, Proc. Natl. Acad. Sci. U. S. A, vol.102, pp.14238-14281, 2005.
, The Tuberous Sclerosis Protein TSC2 Is Not Required for the Regulation of the Mammalian Target of Rapamycin by Amino Acids and Certain Cellular Stresses, J. Biol. Chem, vol.280, pp.18717-18727, 2005.
, Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids, Cell, vol.141, pp.290-303, 2010.
, The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1, Science, vol.320, pp.1496-501, 2008.
, Nutrient-dependent mTORC1 association with the ULK1-Atg13-FIP200 complex required for autophagy, Mol. Biol. Cell, vol.20, pp.1981-91, 2009.
, AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1, Nat. Cell Biol, vol.13, pp.132-173, 2011.
, ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery, Mol. Biol. Cell, vol.20, 1992.
, Regulation of PIK3C3/VPS34 complexes by MTOR in nutrient stress-induced autophagy, Autophagy, vol.9, pp.1983-95, 2013.
, MTORC1 functions as a transcriptional regulator of autophagy by preventing nuclear transport of TFEB, Autophagy, vol.8, pp.903-917, 2012.
, TFEB: A Central Regulator of both the Autophagosome and Lysosome, Hepatology, vol.55, p.1632, 2012.
, The transcription factor TFEB links mTORC1 signaling to transcriptional control of lysosome homeostasis, Sci. Signal, vol.5, p.42, 2012.
, mTOR and lysosome regulation. F1000Prime Rep, vol.6, p.52, 2014.
, Regulation of cap-dependent translation by eIF4E inhibitory proteins, Nature, vol.433, pp.477-480, 2005.
, A Central role for mTOR in lipid homeostasis, Cell Metab, vol.18, pp.465-474, 2013.
, Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth, Proc. Natl. Acad. Sci, vol.108, pp.4129-4134, 2011.
, mTORC1 Controls Mitochondrial Activity and Biogenesis through 4E-BPDependent Translational Regulation, Cell Metab, vol.18, pp.698-711, 2013.
, Regulation of autophagy by a beclin 1-targeted microRNA, miR-30a, in cancer cells, Autophagy, vol.5, pp.816-839, 2009.
, MicroRNA-30a sensitizes tumor cells to cis-platinum via suppressing beclin 1-mediated autophagy, J. Biol. Chem, vol.287, pp.4148-56, 2012.
, Targeting microRNA-30a-mediated autophagy enhances imatinib activity against human chronic myeloid leukemia cells, Leukemia, vol.26, pp.1752-60, 2012.
, MiRNA-30a-mediated autophagy inhibition sensitizes renal cell carcinoma cells to sorafenib, Biochem. Biophys. Res. Commun, vol.459, pp.234-243, 2015.
, Role of MiR-30a in cardiomyocyte autophagy induced by Angiotensin II, J. Renin. Angiotensin. Aldosterone. Syst, vol.16, pp.1-5, 2015.
, Down-regulation of miRNA-30a alleviates cerebral ischemic injury through enhancing beclin 1-mediated autophagy, Neurochem. Res, vol.39, pp.1279-91, 2014.
, Inhibition of Autophagy by MiR-30A Induced by Mycobacteria tuberculosis as a Possible Mechanism of Immune Escape in Human Macrophages, Jpn. J. Infect. Dis, vol.68, pp.420-424, 2015.
, MicroRNA regulation of autophagy, Carcinogenesis, vol.33, pp.2018-2043, 2012.
, Oncogenic and tumor suppressive roles of microRNAs in apoptosis and autophagy, Apoptosis, vol.19, pp.1177-89, 2014.
, MicroRNA: a third dimension in autophagy, Cell Cycle, vol.12, pp.246-50, 2013.
, MicroRNAs in apoptosis, autophagy and necroptosis, Oncotarget, 2015.
, microRNA-101 is a potent inhibitor of autophagy, EMBO J, vol.30, pp.4628-4669, 2011.
, miR-101 inhibits autophagy and enhances cisplatin-induced apoptosis in hepatocellular carcinoma cells, Oncol. Rep, vol.29, pp.2019-2043, 2013.
, Effect of microRNA-101 on proliferation and apoptosis of human osteosarcoma cells by targeting mTOR, J. Huazhong Univ. Sci. Technolog. Med. Sci, vol.34, pp.889-95, 2014.
, miR-101-2, miR-125b-2 and miR-451a act as potential tumor suppressors in gastric cancer through regulation of the PI3K/AKT/mTOR pathway, Cell. Oncol. (Dordr), vol.39, pp.23-33, 2016.
, MiR-34a attenuates paclitaxelresistance of hormone-refractory prostate cancer PC3 cells through direct and indirect mechanisms, Prostate, vol.70, pp.1501-1513, 2010.
, miR-34a modulates angiotensin II-induced myocardial hypertrophy by direct inhibition of ATG9A expression and autophagic activity, PLoS One, vol.9, p.94382, 2014.
, Mir-34: a new weapon against cancer?, Mol. Ther. Nucleic Acids, vol.3, p.194, 2014.
, Genetically engineered oncolytic adenovirus induces autophagic cell death through an E2F1-microRNA-7-epidermal growth factor receptor axis, Int. J. cancer, vol.131, pp.2939-50, 2012.
, microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma, Cancer Res, vol.68, pp.3566-72, 2008.
, EGFR-mediated Beclin 1 phosphorylation in autophagy suppression, tumor progression, and tumor chemoresistance, Cell, vol.154, pp.1269-84, 2013.
, The epidermal growth factor receptor pathway: a model for targeted therapy, Clin. Cancer Res, vol.12, pp.5268-72, 2006.
, miRBase: annotating high confidence microRNAs using deep sequencing data, Nucleic Acids Res, vol.42, pp.68-73, 2014.
, Autophagy Regulatory Network -a systems-level bioinformatics resource for studying the mechanism and regulation of autophagy, Autophagy, vol.11, pp.155-65, 2015.
, Autophagy fights disease through cellular self-digestion, Nature, vol.451, pp.1069-75, 2008.
, The double-edged sword of autophagy modulation in cancer, Clin. Cancer Res, vol.15, pp.5308-5324, 2009.
, Induction of autophagy and inhibition of tumorigenesis by beclin 1, Nature, vol.402, pp.672-678, 1999.
, Cloning and genomic organization of beclin 1, a candidate tumor suppressor gene on chromosome 17q21, Genomics, vol.59, pp.59-65, 1999.
, Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene, J. Clin. Invest, vol.112, pp.1809-1829, 2003.
, Autophagy-deficient mice develop multiple liver tumors, Genes Dev, vol.25, pp.795-800, 2011.
, Tissue-specific autophagy alterations and increased tumorigenesis in mice deficient in Atg4C/autophagin-3, J. Biol. Chem, vol.282, pp.18573-83, 2007.
, The autophagy protein Atg7 is essential for hematopoietic stem cell maintenance, J. Exp. Med, vol.208, pp.455-67, 2011.
, U2AF35(S34F) Promotes Transformation by Directing Aberrant ATG7 PremRNA 3? End Formation, Mol. Cell, vol.62, pp.479-490, 2016.
, Autophagy in malignant transformation and cancer progression, EMBO J, vol.34, pp.856-880, 2015.
, Hallmarks of cancer: The next generation, Cell, vol.144, pp.646-674, 2011.
, Bcl-2 family proteins and cancer, Oncogene, vol.27, pp.6398-6406, 2008.
DOI : 10.1038/onc.2008.307
, Genomic instability and cancer: an introduction, J. Mol. Cell Biol, vol.3, pp.1-3, 2011.
DOI : 10.1093/jmcb/mjq057
URL : https://academic.oup.com/jmcb/article-pdf/3/1/1/2700914/mjq057.pdf
, Autophagy suppresses tumor progression by limiting chromosomal instability, Genes Dev, vol.21, pp.1367-1381, 2007.
DOI : 10.1101/gad.1545107
URL : http://genesdev.cshlp.org/content/21/11/1367.full.pdf
, The signaling adaptor p62 is an important NF-kappaB mediator in tumorigenesis, Cancer Cell, vol.13, pp.343-54, 2008.
, How mitochondria produce reactive oxygen species, Biochem. J, vol.417, pp.1-13, 2009.
DOI : 10.1042/bj20081386
URL : http://www.biochemj.org/content/417/1/1.full.pdf
, Immunity, inflammation, and cancer. Cell, vol.140, pp.883-99, 2010.
, Autophagy in infection, inflammation and immunity, Nat. Rev. Immunol, vol.13, pp.722-737, 2013.
DOI : 10.1038/nri3532
URL : http://europepmc.org/articles/pmc5340150?pdf=render
, Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis, Cancer Cell, vol.10, pp.51-64, 2006.
DOI : 10.1016/j.ccr.2006.06.001
URL : https://doi.org/10.1016/j.ccr.2006.06.001
, How dying cells alert the immune system to danger, Nat. Rev. Immunol, vol.8, pp.279-89, 2008.
DOI : 10.1038/nri2215
URL : http://europepmc.org/articles/pmc2763408?pdf=render
, Inflammasomes in carcinogenesis and anticancer immune responses, Nat. Immunol, vol.13, pp.343-51, 2012.
DOI : 10.1038/ni.2224
, Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome, Nat. Immunol, vol.12, pp.222-252, 2011.
, IL-1 receptor blockade restores autophagy and reduces inflammation in chronic granulomatous disease in mice and in humans, Proc. Natl. Acad. Sci. U. S. A, vol.111, pp.3526-3557, 2014.
, Autophagy in immunity and inflammation, Nature, vol.469, pp.323-358, 2011.
, Xenophagy in Helicobacter pylori-and Epstein-Barr virus-induced gastric cancer, J. Pathol, vol.233, pp.103-115, 2014.
, Understanding the Warburg effect: the metabolic requirements of cell proliferation, Science, vol.324, pp.1029-1062, 2009.
, Hallmarks of Cancer: The Next Generation, Cell, vol.144, pp.646-674, 2011.
, Metabolic targets for cancer therapy, Nat. Rev. Drug Discov, vol.12, pp.829-846, 2013.
, Cell biology. Metabolic control of cell death, Science, vol.345, p.1250256, 2014.
, Another way to die: autophagic programmed cell death, Cell Death Differ, vol.12, pp.1528-1534, 2005.
DOI : 10.1038/sj.cdd.4401777
URL : https://www.nature.com/articles/4401777.pdf
, Autophagic cell death: Loch Ness monster or endangered species, Autophagy, vol.7, pp.457-65, 2011.
DOI : 10.4161/auto.7.5.14226
, Autophagic cell death: the story of a misnomer, Nat. Rev. Mol. Cell Biol, vol.9, pp.1004-1014, 2008.
, Cell death by autophagy: emerging molecular mechanisms and implications for cancer therapy, Oncogene, vol.34, pp.5105-5113, 2015.
DOI : 10.1038/onc.2014.458
, The end of autophagic cell death?, Autophagy, vol.8, pp.1-3, 2012.
, Autophagy and SQSTM1 on the RHOA(d) again, 2013.
DOI : 10.4161/auto.27198
URL : http://europepmc.org/articles/pmc5396087?pdf=render
, Autophagy mediates degradation of nuclear lamina, Nature, vol.527, pp.105-109, 2015.
DOI : 10.1038/nature15548
URL : http://europepmc.org/articles/pmc4824414?pdf=render
, Many roads lead to oncogene-induced senescence, Oncogene, vol.27, pp.2801-2809, 2008.
DOI : 10.1038/sj.onc.1210950
URL : https://www.nature.com/articles/1210950.pdf
, Autophagy in tumorigenesis and energy metabolism: friend by day, foe by night, Curr. Opin. Genet. Dev, vol.21, pp.113-119, 2011.
DOI : 10.1016/j.gde.2010.12.008
URL : http://europepmc.org/articles/pmc3039840?pdf=render
, Eating to exit: autophagy-enabled senescence revealed
DOI : 10.1101/gad.1795309
URL : http://genesdev.cshlp.org/content/23/7/784.full.pdf
, Autophagy Mediates Tumor Suppression via Cellular Senescence, Trends Cell Biol, vol.26, pp.1-3, 2016.
DOI : 10.1016/j.tcb.2015.11.001
, Autophagy and senescence in cancer therapy, J. Cell. Physiol, vol.229, pp.6-9, 2014.
DOI : 10.1002/jcp.24420
, Autophagy maintains stemness by preventing senescence, Nature, vol.529, pp.37-42, 2016.
, Accumulation of p62/SQSTM1 is associated with poor prognosis in patients with lung adenocarcinoma, Cancer Sci, vol.103, pp.760-766, 2012.
, p62 overexpression in breast tumors and regulation by prostate-derived Ets factor in breast cancer cells, Oncogene, vol.22, pp.2322-2355, 2003.
DOI : 10.1038/sj.onc.1206325
URL : https://www.nature.com/articles/1206325.pdf
, The ubiquitin-binding protein p62 is expressed in breast cancers showing features of aggressive disease, Endocr. Relat. Cancer, vol.14, pp.73-80, 2007.
, When autophagy meets cancer through p62/SQSTM1, Am. J. Cancer Res, vol.2, pp.397-413, 2012.
, Autophagy contributes to therapy-induced degradation of the PML/RARA oncoprotein, Blood, vol.116, pp.2324-2355, 2010.
, Oncogene Addiction. Cancer Res, vol.68, pp.3077-3080, 2008.
, Dietary downregulation of mutant p53 levels via glucose restriction: mechanisms and implications for tumor therapy, Cell Cycle, vol.11, pp.4436-4482, 2012.
, Dissecting the pathways that destabilize mutant p53: the proteasome or autophagy, Cell Cycle, vol.12, pp.1022-1031, 2013.
, When Cells Suffocate: Autophagy in Cancer and Immune Cells under Low Oxygen, Int. J. Cell Biol, p.470597, 2011.
DOI : 10.1155/2011/470597
URL : http://downloads.hindawi.com/journals/ijcb/2011/470597.pdf
, Autophagy and Cellular Immune Responses, Immunity, vol.39, pp.211-227, 2013.
, Alternative pathways for MHC class I presentation: a new function for autophagy, Cell. Mol. Life Sci, vol.68, pp.1533-1574, 2011.
, Antigen-loading compartments for major histocompatibility complex class II molecules continuously receive input from autophagosomes, Immunity, vol.26, pp.79-92, 2007.
, Temporal regulation of intracellular organelle homeostasis in T lymphocytes by autophagy, J. Immunol, vol.186, pp.5313-5335, 2011.
, Autophagy promotes T-cell survival through degradation of proteins of the cell death machinery, Cell Death Differ, vol.19, pp.144-52, 2012.
, Autophagy in non-small cell lung carcinogenesis: A positive regulator of antitumor immunosurveillance, Autophagy, vol.10, pp.529-560, 2014.
, Involvement of autophagy in oncogenic K-Ras-induced malignant cell transformation, J. Biol. Chem, vol.286, pp.12924-12956, 2011.
, Tumorigenesis in tuberous sclerosis complex is autophagy and p62/sequestosome 1 (SQSTM1)-dependent, Proc. Natl. Acad. Sci. U. S. A, vol.108, pp.12455-60, 2011.
, Hypoxia and defective apoptosis drive genomic instability and tumorigenesis, Genes Dev, vol.18, pp.2095-107, 2004.
, Pancreatic cancers require autophagy for tumor growth, Genes Dev, vol.25, pp.717-746, 2011.
, Autophagy, Warburg, and Warburg reverse effects in human cancer, Biomed Res. Int, p.926729, 2014.
, Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis, Genes Dev, vol.25, pp.460-70, 2011.
, Warburg Meets Autophagy: Cancer-Associated Fibroblasts Accelerate Tumor Growth and Metastasis via Oxidative Stress, Mitophagy, and Aerobic Glycolysis, 2012.
, Interplay between ROS and autophagy in cancer cells, from tumor initiation to cancer therapy, Redox Biol, vol.4, pp.184-192, 2015.
, Autophagy-induced tumor dormancy in ovarian cancer, J. Clin. Invest, vol.118, pp.3837-3877, 2008.
, Autophagy and metastasis: another double-edged sword, Curr. Opin. Cell Biol, vol.22, pp.241-246, 2010.
, Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function, Nature, vol.514, pp.628-660, 2014.
, Inhibition of the autophagic flux by salinomycin in breast cancer stemlike/progenitor cells interferes with their maintenance, Autophagy, vol.9, pp.714-743, 2013.
, Autophagy inhibition suppresses the tumorigenic potential of cancer stem cell enriched side population in bladder cancer, Biochim. Biophys. Acta -Mol. Basis Dis, vol.1842, pp.2073-2086, 2014.
, Autophagy contributes to the survival of CD133+ liver cancer stem cells in the hypoxic and nutrient-deprived tumor microenvironment, Cancer Lett, vol.339, pp.70-81, 2013.
, Mechanisms of disseminated cancer cell dormancy: an awakening field, Nat. Rev. Cancer, vol.14, pp.611-633, 2014.
, Autophagy, senescence and tumor dormancy in cancer therapy, Autophagy, vol.5, pp.1232-1236, 2009.
, Dissemination and growth of cancer cells in metastatic sites, Nat. Rev. Cancer, vol.2, pp.563-72, 2002.
, Autophagy regulates selective HMGB1 release in tumor cells that are destined to die, Cell Death Differ, vol.16, pp.175-83, 2009.
, Involvement of protective autophagy in TRAIL resistance of apoptosis-defective tumor cells, J. Biol. Chem, vol.283, pp.19665-77, 2008.
, Mutations of tumor necrosis factor-related apoptosis-inducing ligand receptor 1 (TRAIL-R1) and receptor 2 (TRAIL-R2) genes in metastatic breast cancers, Cancer Res, vol.61, pp.4942-4948, 2001.
, Induction of autophagy during extracellular matrix detachment promotes cell survival, Mol. Biol. Cell, vol.19, pp.797-806, 2008.
, Uncoordinated 51-like kinase 2 signaling pathway regulates epithelialmesenchymal transition in A549 lung cancer cells, FEBS Lett, vol.590, pp.1365-74, 2016.
, Autophagy may promote carcinoma cell invasion and correlate with poor prognosis in cholangiocarcinoma, Int. J. Clin. Exp. Pathol, vol.7, pp.4913-4934, 2014.
, Autophagy induction impairs migration and invasion by reversing EMT in glioblastoma cells, Mol. Oncol, vol.9, pp.1612-1625, 2015.
, Autophagy regulates hepatocyte identity and epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions promoting Snail degradation, Cell Death Dis, vol.6, p.1880, 2015.
, Role of autophagy in cancer prevention, Cancer Prev. Res. (Phila), vol.4, pp.973-83, 2011.
, The dynamic nature of autophagy in cancer, Genes Dev, vol.25, 1999.
, The four faces of autophagy: implications for cancer therapy, Cancer Res, vol.74, pp.647-51, 2014.
, When cytoprotective autophagy isn't? and even when it is, Autophagy, vol.10, pp.391-393, 2014.
, Targeting autophagy in cancer management -strategies and developments, Cancer Manag. Res, vol.7, pp.291-300, 2015.
, Targeting autophagy potentiates tyrosine kinase inhibitor -induced cell death in Philadelphia chromosome -positive cells , including primary CML stem cells
, Targeting autophagy potentiates the apoptotic effect of histone deacetylase inhibitors in t(8;21) AML cells, Blood, vol.122, pp.2467-2476, 2013.
, Dual functions of autophagy in the response of breast tumor cells to radiation: cytoprotective autophagy with radiation alone and cytotoxic autophagy in radiosensitization by vitamin D 3, Autophagy, vol.8, pp.739-53, 2012.
, Autophagy is needed for the growth of pancreatic adenocarcinoma and has a cytoprotective effect against anticancer drugs, Eur. J. Cancer, vol.50, pp.1382-90, 2014.
, Honokiol activates reactive oxygen species-mediated cytoprotective autophagy in human prostate cancer cells, Prostate, vol.74, pp.1209-1230, 2014.
, Downregulation of ATG14 by EGR1-MIR152 sensitizes ovarian cancer cells to cisplatin-induced apoptosis by inhibiting cyto-protective autophagy, Autophagy, vol.11, pp.373-84, 2015.
, EGFR tyrosine kinase inhibitors activate autophagy as a cytoprotective response in human lung cancer cells, PLoS One, vol.6, p.18691, 2011.
, Targeting autophagy to sensitive glioma to temozolomide treatment, J. Exp. Clin. Cancer Res, vol.35, p.23, 2016.
, Role of autophagy in histone deacetylase inhibitor-induced apoptotic and nonapoptotic cell death, Proc. Natl. Acad. Sci. U. S. A, vol.109, pp.6561-6566, 2012.
, Autophagy inhibition and antimalarials promote cell death in gastrointestinal stromal tumor (GIST), Proc. Natl. Acad. Sci. U. S. A, vol.107, pp.14333-14338, 2010.
, Cell death by autophagy: emerging molecular mechanisms and implications for cancer therapy, Oncogene, vol.34, pp.5105-5113, 2015.
, Silencing of Bcl-2 expression by small interfering RNA induces autophagic cell death in MCF-7 breast cancer cells, Autophagy, vol.4, pp.669-679, 2008.
, Synergistic Tumor-Killing Effect of Radiation and Berberine Combined Treatment in Lung Cancer: The Contribution of Autophagic Cell Death, Int. J. Radiat. Oncol, vol.70, pp.529-542, 2008.
, Aerosol delivery of beclin1 enhanced the anti-tumor effect of radiation in the lungs of K-rasLA1 mice, J. Radiat. Res, vol.53, pp.506-521, 2012.
, Clozapine induces autophagic cell death in non-small cell lung cancer cells, Cell. Physiol. Biochem, vol.35, pp.945-56, 2015.
, Impact of autophagy inhibition at different stages on cytotoxic effect of autophagy inducer in glioblastoma cells, Cell. Physiol. Biochem, vol.35, pp.1303-1319, 2015.
, Synergistic Augmentation of Rapamycin-Induced Autophagy in Malignant Glioma Cells by Phosphatidylinositol 3-Kinase/Protein Kinase B Inhibitors, Cancer Res, vol.65, pp.3336-3346, 2005.
, Stimulation of ALK by the growth factor midkine renders glioma cells resistant to autophagy-mediated cell death, Autophagy, vol.7, pp.1071-1073, 2011.
, Cell death induced by dexamethasone in lymphoid leukemia is mediated through initiation of autophagy, Cell Death Differ, vol.16, pp.1018-1047, 2009.
, Autophagy as the main means of cytotoxicity by glucocorticoids in hematological malignancies, Autophagy, vol.5, pp.1198-200, 2009.
, Resveratrol promotes autophagic cell death in chronic myelogenous leukemia cells via JNK-mediated p62/SQSTM1 expression and AMPK activation, Cancer Res, vol.70, pp.1042-52, 2010.
, A novel cytostatic form of autophagy in sensitization of non-small cell lung cancer cells to radiation by vitamin D and the vitamin D analog, EB 1089, Autophagy, vol.10, pp.2346-61, 2014.
, Ivermectin induces cytostatic autophagy by blocking PAK1/Akt axis in breast cancer, Cancer Res. canres.2887, p.2015, 2016.
, Autophagy Inhibition for Chemosensitization and Radiosensitization in Cancer: Do the Preclinical Data Support This Therapeutic Strategy?, J. Pharmacol. Exp. Ther, vol.344, pp.544-552, 2013.
, Yet Another Function of p53--The Switch That Determines Whether Radiation-Induced Autophagy Will Be Cytoprotective or Nonprotective: Implications for Autophagy Inhibition as a Therapeutic Strategy, Mol. Pharmacol, vol.87, pp.803-814, 2015.
, A switch between cytoprotective and cytotoxic autophagy in the radiosensitization of breast tumor cells by chloroquine and vitamin D, Horm. Cancer, vol.2, pp.272-85, 2011.
, The BCL-2 protein family: opposing activities that mediate cell death, Nat. Rev. Mol. Cell Biol, vol.9, pp.47-59, 2008.
, The inhibition of autophagy sensitises colon cancer cells with wild-type p53 but not mutant p53 to topotecan treatment, PLoS One, vol.7, p.45058, 2012.
, Knockdown of autophagy-related protein 5, ATG5, decreases oxidative stress and has an opposing effect on camptothecin-induced cytotoxicity in osteosarcoma cells, BMC Cancer, vol.13, p.500, 2013.
, Vorinostat-induced autophagy switches from a death-promoting to a cytoprotective signal to drive acquired resistance, Cell Death Dis, vol.4, p.486, 2013.
, Involvement of the bcl-2 gene in human follicular lymphoma, Science, vol.228, pp.1440-1443, 1985.
, BH3-only proteins in apoptosis and beyond: an overview, Oncogene, vol.27, issue.1, pp.2-19, 2008.
, Apoptosis: a review of programmed cell death, Toxicol. Pathol, vol.35, pp.495-516, 2007.
, Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy, Oncogene, vol.25, pp.4798-4811, 2006.
, Intrinsically disordered proteins in bcl-2 regulated apoptosis, Int. J. Mol. Sci, vol.11, pp.1808-1832, 2010.
, Protection against fatal Sindbis virus encephalitis by beclin, a novel Bcl-2-interacting protein, J. Virol, vol.72, pp.8586-96, 1998.
, Crystal structure of the Bcl-XL-Beclin 1 peptide complex: Beclin 1 is a novel BH3-only protein, J. Biol. Chem, vol.282, pp.13123-13155, 2007.
, Self-eating and self-killing: crosstalk between autophagy and apoptosis, Nat. Rev. Mol. Cell Biol, vol.8, pp.741-52, 2007.
DOI : 10.1038/nrm2239
, Recent insights into cell death and autophagy, FEBS J, vol.282, pp.4279-4288, 2015.
DOI : 10.1111/febs.13515
URL : https://febs.onlinelibrary.wiley.com/doi/pdf/10.1111/febs.13515
, Self-consumption: the interplay of autophagy and apoptosis, Nat. Rev. Mol. Cell Biol, vol.15, pp.81-94, 2014.
, The pro-survival role of autophagy depends on Bcl-2 under nutrition stress conditions, PLoS One, vol.8, p.63232, 2013.
, Control of autophagic cell death by caspase-10 in multiple myeloma, Cancer Cell, vol.23, pp.435-484, 2013.
, MicroRNAs as regulators of apoptosis mechanisms in cancer, Clujul Med, vol.89, pp.50-55, 2016.
, MicroRNAs in autophagy and their emerging roles in crosstalk with apoptosis, Autophagy, vol.8, pp.873-82, 2012.
DOI : 10.4161/auto.19629
URL : http://europepmc.org/articles/pmc3427253?pdf=render
, Autophagy inhibitors. Cell. Mol. Life Sci, vol.73, pp.985-1001, 2016.
, Time to use a dose of Chloroquine as an adjuvant to anti-cancer chemotherapies, Eur. J. Pharmacol, vol.771, pp.139-183, 2016.
, Chloroquine activates the p53 pathway and induces apoptosis in human glioma cells, Neuro. Oncol, vol.12, pp.389-400, 2010.
, Chloroquine enhances TRAIL-mediated apoptosis through up-regulation of DR5 by stabilization of mRNA and protein in cancer cells, Sci. Rep, vol.6, pp.611-620, 2016.
, Tumor vessel normalization by chloroquine independent of autophagy, Cancer Cell, vol.26, pp.190-206, 2014.
DOI : 10.1016/j.ccr.2014.06.025
URL : https://doi.org/10.1016/j.ccr.2014.06.025
, Chloroquine in cancer therapy: a double-edged sword of autophagy, Cancer Res, vol.73, pp.3-7, 2013.
, Immunosuppressive effects of chloroquine: potential effectiveness for treatment of post-transfusion graft-versus-host disease, Transfus. Med, vol.8, pp.209-223, 1998.
, Autophagy inhibition enhances therapy-induced apoptosis in a Mycinduced model of lymphoma, J. Clin. Invest, vol.117, pp.326-336, 2007.
, Acidic extracellular pH neutralizes the autophagy-inhibiting activity of chloroquine: implications for cancer therapies, Autophagy, vol.10, pp.562-71, 2014.
, Development of autophagy inducers in clinical medicine, J. Clin. Invest, vol.125, pp.14-24, 2015.
, Autophagy inhibitor Lys05 has single-agent antitumor activity and reproduces the phenotype of a genetic autophagy deficiency, Proc. Natl. Acad. Sci, vol.109, pp.8253-8258, 2012.
, Shaping development of autophagy inhibitors with the structure of the lipid kinase Vps34, Science, vol.327, pp.1638-1680, 2010.
, PI3K and cancer: lessons, challenges and opportunities, Nat. Rev. Drug Discov, vol.13, pp.140-56, 2014.
DOI : 10.1038/nrd4204
URL : http://europepmc.org/articles/pmc3994981?pdf=render
, Beclin1 controls the levels of p53 by regulating the deubiquitination activity of USP10 and USP13, Cell, vol.147, pp.223-257, 2011.
, Spautin-1, a novel autophagy inhibitor, enhances imatinib-induced apoptosis in chronic myeloid leukemia, Int. J. Oncol, vol.44, pp.1661-1668, 2014.
, Small Molecule Inhibition of the Autophagy Kinase ULK1 and Identification of ULK1 Substrates, Mol. Cell, 2015.
, Pharmacological Inhibition of ULK1 Blocks mTOR-Dependent Autophagy, J. Biol. Chem, vol.290, pp.11376-83, 2015.
DOI : 10.1074/jbc.c114.627778
URL : http://www.jbc.org/content/290/18/11376.full.pdf
, Autophagy in tumor suppression and cancer therapy, Crit. Rev. Eukaryot. Gene Expr, vol.21, pp.71-100, 2011.
DOI : 10.1615/critreveukargeneexpr.v21.i1.50
URL : http://europepmc.org/articles/pmc3187613?pdf=render
, A rapamycin derivative (everolimus) controls proliferation through downregulation of truncated CCAAT enhancer binding protein {beta} and NF-{kappa}B activity in Hodgkin and anaplastic large cell lymphomas, Blood, vol.106, pp.1801-1808, 2005.
, MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients, Br. J. Cancer, vol.113, pp.569-573, 2015.
, miR-Test: a blood test for lung cancer early detection, J. Natl. Cancer Inst, vol.107, p.63, 2015.
, The clinical and biological significance of MIR-224 expression in colorectal cancer metastasis, Gut, vol.65, pp.977-89, 2016.
, MiR-200a regulates epithelial to mesenchymal transition-related gene expression and determines prognosis in colorectal cancer patients, Br. J. Cancer, vol.110, pp.1614-1635, 2014.
, Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma, Blood, vol.125, pp.1137-1182, 2015.
, Clinical applications of microRNAs, vol.2, p.136, 2013.
, Autophagy and autophagic cell death are next targets for elimination of the resistance to tyrosine kinase inhibitors, Cancer Sci, vol.99, pp.2200-2208, 2008.
, Drug combination studies and their synergy quantification using the Chou-Talalay method, Cancer Res, vol.70, pp.440-446, 2010.
, A microRNA imparts robustness against environmental fluctuation during development, Cell, vol.137, pp.273-82, 2009.
, Evidence for a microRNA expansion in the bilaterian ancestor, Dev. Genes Evol, vol.217, pp.73-80, 2007.
, Clinical Potential of microRNA-7 in Cancer, J. Clin. Med, vol.4, pp.1668-1687, 2015.
, A mammalian microRNA expression atlas based on small RNA library sequencing, Cell, vol.129, pp.1401-1415, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00159802
, The widespread impact of mammalian MicroRNAs on mRNA repression and evolution, Science, vol.310, pp.1817-1838, 2005.
, MicroRNA miR-7 is preferentially expressed in endocrine cells of the developing and adult human pancreas, Gene Expr. Patterns, vol.9, pp.193-202, 2009.
, Widespread microRNA repression by Myc contributes to tumorigenesis, Nat. Genet, vol.40, pp.43-50, 2008.
, Transcriptome-wide analysis of regulatory interactions of the RNA-binding protein HuR, Mol. Cell, vol.43, pp.340-52, 2011.
, TLR9 signaling repressed tumor suppressor miR-7 expression through upregulation of HuR in human lung cancer cells, Cancer Cell Int, vol.13, p.90, 2013.
, Essential role of IRF4 and MYC signaling for survival of anaplastic large cell lymphoma, Blood, vol.125, pp.124-156, 2015.
, HuR-mediated control of C/EBPbeta mRNA stability and translation in ALKpositive anaplastic large cell lymphomas, Mol. Cancer Res, vol.9, pp.485-96, 2011.
, MicroRNA-7: a promising new target in cancer therapy, Cancer Cell Int, vol.15, p.103, 2015.
, Relationship between expression of onco-related miRNAs and the endoscopic appearance of colorectal tumors, Int. J. Mol. Sci, vol.16, pp.1526-1569, 2015.
, MiR-7 promotes epithelial cell transformation by targeting the tumor suppressor KLF4, PLoS One, vol.9, p.103987, 2014.
, The Majority of MicroRNAs Detectable in Serum and Saliva Is Concentrated in Exosomes, PLoS One, vol.7, p.30679, 2012.
, Isolation and Quantification of MicroRNAs from Urinary Exosomes/Microvesicles for Biomarker Discovery, Int. J. Biol. Sci, vol.9, pp.1021-1031, 2013.
, A plasma microRNA panel for early detection of colorectal cancer, Int. J. cancer, vol.136, pp.152-61, 2015.
, Systemic miRNA-7 delivery inhibits tumor angiogenesis and growth in murine xenograft glioblastoma, Oncotarget, vol.5, pp.6687-700, 2014.
, Regulation of epidermal growth factor receptor signaling by plasmid-based microRNA-7 inhibits human malignant gliomas growth and metastasis in vivo, Neoplasma, vol.60, pp.274-83, 2013.
, Trichostatin A Suppresses EGFR Expression through Induction of MicroRNA-7 in an HDAC-Independent Manner in Lapatinib-Treated Cells, Biomed Res. Int, pp.1-11, 2014.
, Regulation of Epidermal Growth Factor Receptor Signaling and Erlotinib Sensitivity in Head and Neck Cancer Cells by miR-7, PLoS One, vol.7, p.47067, 2012.
, MicroRNA-7 sensitizes non-small cell lung cancer cells to paclitaxel, Oncol. Lett, vol.8, pp.2193-2200, 2014.
, MicroRNA-7 enhances cytotoxicity induced by gefitinib in non-small cell lung cancer via inhibiting the EGFR and IGF1R signalling pathways, Contemp. Oncol, vol.19, pp.201-207, 2015.
, Crizotinib induces autophagy through inhibition of the STAT3 pathway in multiple lung cancer cell lines, Oncotarget, vol.5, 2015.
, Bcl-2 expression in anaplastic large cell lymphoma, Am. J. Pathol, vol.158, pp.1889-90, 2001.
, Induction of autophagy contributes to crizotinib resistance in ALK-positive lung cancer, vol.15, pp.570-577, 2014.
, Combating autophagy is a strategy to increase cytotoxic effects of novel ALK inhibitor entrectinib in neuroblastoma cells, Oncotarget, vol.7, pp.5646-63, 2016.
, Novel ALK inhibitor AZD3463 inhibits neuroblastoma growth by overcoming crizotinib resistance and inducing apoptosis, Sci. Rep, vol.6, p.19423, 2016.
, The role of autophagy in doxorubicin-induced cardiotoxicity, Life Sci, vol.93, pp.913-916, 2013.
, Inhibition of doxorubicin-induced autophagy in hepatocellular carcinoma Hep3B cells by sorafenib--the role of extracellular signalregulated kinase counteraction, FEBS J, vol.278, pp.3494-507, 2011.
, Differential expression of autophagy in Hodgkin lymphoma cells treated with various anti-cancer drugs, Acta Med. Indones, vol.39, pp.153-159
, Autophagy and microtubules -new story, old players, J. Cell Sci, vol.126, pp.1071-80, 2013.
, The role of autophagy in cancer development and response to therapy, Nat Rev Cancer, vol.5, pp.726-734, 2005.
, Microtubules facilitate autophagosome formation and fusion of autophagosomes with endosomes, Traffic, vol.7, pp.129-174, 2006.
, Microtubules Support Production of Starvation-induced Autophagosomes but Not Their Targeting and Fusion with Lysosomes, J. Biol. Chem, vol.281, pp.36303-36316, 2006.
, Metabolic Stress in Autophagy and Cell Death Pathways, Cold Spring Harb. Perspect. Biol, vol.4, pp.8763-008763, 2012.
, Oncogene addiction: setting the stage for molecularly targeted cancer therapy, Genes Dev, vol.21, pp.3214-3231, 2007.
, Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells, J. Clin. Invest, vol.119, pp.1109-1123, 2009.
, Inhibition of c-Met promoted apoptosis, autophagy and loss of the mitochondrial transmembrane potential in oridonin-induced A549 lung cancer cells, J. Pharm. Pharmacol, vol.65, pp.1622-1664, 2013.
, Measuring Autophagy in the Context of Cancer, Adv. Exp. Med. Biol, vol.899, pp.121-164, 2016.
, TRANSAUTOPHAGY: European network for multidisciplinary research and translation of autophagy knowledge, Autophagy, vol.12, pp.614-617, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01911119
, Immunohistochemical analysis of macroautophagy : Recommendations and limitations, pp.1-17, 2013.
, Autophagy: Assays and artifacts, J. Pathol, vol.221, pp.117-124, 2010.
, ALK+ALCLs induce cutaneous, HMGB-1-dependent IL-8/CXCL8 production by keratinocytes through NF-?B activation, Blood, vol.119, pp.4698-707, 2012.
, Autophagy Inhibition Compromises Degradation of Ubiquitin-Proteasome Pathway Substrates, Mol. Cell, vol.33, pp.517-527, 2009.
, Cullin3-Based Polyubiquitination and p62-Dependent Aggregation of Caspase-8
, Mediate Extrinsic Apoptosis Signaling. Cell, vol.137, pp.721-735, 2009.
, Hypoxiaactivated autophagy accelerates degradation of SQSTM1/p62, Oncogene, vol.28, pp.334-378, 2009.
, IMP2/p62 induces genomic instability and an aggressive hepatocellular carcinoma phenotype, Cell Death Dis, vol.6, p.1894, 2015.
, Autophagic degradation of active caspase-8: a crosstalk mechanism between autophagy and apoptosis, Autophagy, vol.6, pp.891-900, 2010.
, Autophagy Controls the Kinetics and Extent of Mitochondrial Apoptosis by Regulating PUMA Levels, 2014.
, Autophagy proteins regulate ERK phosphorylation, Nat. Commun, vol.4, p.2799, 2013.
, Activated human NK and CD8+ T cells express both TNF-related apoptosisinducing ligand (TRAIL) and TRAIL receptors but are resistant to TRAIL-mediated cytotoxicity, Blood, vol.104, pp.2418-2442, 2004.
, Rapamycin pretreatment protects against apoptosis, Hum. Mol. Genet, vol.15, pp.1209-1216, 2006.
, Rapamycin reduces reactive oxygen species in cultured human corneal endothelial cells, Curr. Eye Res, vol.36, pp.1116-1138, 2011.
, Activation of mammalian target of rapamycin signaling pathway contributes to tumor cell survival in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma, Cancer Res, vol.66, pp.6589-97, 2006.
, Prognostic significance and therapeutic potential of the activation of anaplastic lymphoma kinase/protein kinase B/mammalian target of rapamycin signaling pathway in anaplastic large cell lymphoma, BMC Cancer, vol.13, p.471, 2013.
, MAPK15 mediates BCR-ABL1-induced autophagy and regulates oncogenedependent cell proliferation and tumor formation, Autophagy, vol.11, pp.1790-1802, 2015.
, Beta 1-integrin-c-Met cooperation reveals an inside-in survival signalling on autophagy-related endomembranes, Nat. Commun, vol.7, p.11942, 2016.
URL : https://hal.archives-ouvertes.fr/hal-02153698
, Autophagosomal membrane serves as platform for intracellular deathinducing signaling complex (iDISC)-mediated caspase-8 activation and apoptosis, J. Biol. Chem, vol.287, pp.12455-68, 2012.
, UNC51-like kinase 1, autophagic regulator and cancer therapeutic target, Cell Prolif, vol.47, pp.494-505, 2014.
, Regulation of epidermal growth factor receptor signaling in human cancer cells by microRNA-7, J. Biol. Chem, vol.284, pp.5731-5772, 2009.
, miR-7 inhibits glioblastoma growth by simultaneously interfering with the PI3K/ATK and Raf/MEK/ERK pathways, Int. J. Oncol, vol.44, pp.1571-1580, 2014.
, MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma, Hepatology, vol.55, pp.1852-1862, 2012.
, Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy, Nat. Rev. Mol. Cell Biol, vol.15, pp.49-63, 2013.
, Bcl-2:Beclin 1 complex: multiple, mechanisms regulating autophagy/apoptosis toggle switch, Am. J. Cancer Res, vol.2, pp.214-235, 2012.
, MicroRNA-7 Inhibits the Growth of Human Non-Small Cell Lung Cancer A549 Cells through Targeting BCL-2, Int. J. Biol. Sci, pp.805-814, 2011.
, The Bcl-2 family: roles in cell survival and oncogenesis, Oncogene, vol.22, pp.8590-8607, 2003.
, The Pro-Survival Role of Autophagy Depends on Bcl-2 Under Nutrition Stress Conditions, PLoS One, vol.8, p.63232, 2013.
, Bcl-2 Phosphorylation Triggers Autophagy Switch and Reduces Mitochondrial Damage in Limb Remote Ischemic Conditioned Rats After Ischemic Stroke, Transl. Stroke Res, vol.6, pp.198-206, 2015.
, Bcl-2 Antiapoptotic Proteins Inhibit Beclin 1-Dependent Autophagy, Cell, vol.122, pp.927-939, 2005.
, Oncogenic tyrosine kinase NPM/ALK induces activation of the rapamycinsensitive mTOR signaling pathway, Oncogene, vol.26, pp.5606-5620, 2007.
, Amino acids interfere with the ERK1/2-dependent control of macroautophagy by controlling the activation of Raf-1 in human colon cancer HT-29 cells, J. Biol. Chem, vol.278, pp.16667-74, 2003.
, Involvement of PKC signal pathways in oridonin-induced autophagy in HeLa cells: a protective mechanism against apoptosis, Biochem. Biophys. Res. Commun, vol.378, pp.273-281, 2009.
, Crosstalk between autophagy and apoptosis in the regulation of paclitaxel-induced cell death in v-Ha-ras-transformed fibroblasts, Mol. Cell. Biochem, vol.348, pp.61-68, 2011.
, Conditional expression of oncogenic C-RAF in mouse pulmonary epithelial cells reveals differential tumorigenesis and induction of autophagy leading to tumor regression, Neoplasia, vol.13, pp.1005-1023, 2011.
, Raf family kinases: old dogs have learned new tricks, Genes Cancer, vol.2, pp.232-60, 2011.
DOI : 10.1177/1947601911407323
URL : http://europepmc.org/articles/pmc3128629?pdf=render
, Ras-related tumorigenesis is suppressed by BNIP3-mediated autophagy through inhibition of cell proliferation, Neoplasia, vol.13, pp.1171-82, 2011.
, MicroRNA-7 inhibits the growth of human non-small cell lung cancer A549 cells through targeting BCL-2, Int. J. Biol. Sci, vol.7, pp.805-819, 2011.
, Use of MicroRNA Expression Levels to Predict Outcomes in Resected Stage I Non-small Cell Lung Cancer, J. Thorac. Oncol, vol.5, pp.1755-1763, 2010.
, Antibody-mediated delivery of anti-KRAS-siRNA in vivo overcomes therapy resistance in colon cancer, Clin. Cancer Res, vol.21, pp.1383-94, 2015.
, Antibody-coupled siRNA as an efficient method for in vivo mRNA